pde2 in hf, pka subunits, interagency, valve replacement, primary symptom, adult patients, community study, assessments, 12-lead ecg, dose-related, interface, vascular endothelial growth factor blockade, echocardiography with measurement, performance, association class iii, first research, hypokalemia with spironolactone, body mass, diffuse myocardial changes, higher risk for hhf, substudy, pre-hct, single-institution cohort, social support, sternal sparing approach, grading system, lateral, lvad insertion, akt→forkhead, perceived barriers, moderate-quality, secondary, resynchronization-defibrillation, consideration, rvpo, schfi, potential benefit, purpose of review, consumption, study population, increase in lv, influx via l-type, 5-year follow-up period, breast cancer patients, myocardial infarction heart, follow, mortality outcomes of heart failure, nontrastuzumab users, arrhythmias, af, low sst2, ceballos, mass spectrometric analysis, energy, correlation between changes, post-dash, hemostasis in patients, nonstandardized n-terminal pro-b-type, pathophysiology, english-language, hfpsi use, single-arm, failure questionnaire, cardiac centre, nonspecific, identify factors, percent relative reduction in 30-day readmission rate, outcomes of exercise training, medical outcomes study short-form quality of life domains, pulmonary arteries, association, peripheral oedema, reverses, resting tension, contractile reserve, acids, conversations, centre in canada, milliseconds, performance goal, pde2, forty-six, low left ventricular ejection fractions, ivabradine group, scn5a variants, undiagnosed, including stress echocardiography, ii lvad, health initiative, coronary artery calcium scores, new therapeutic approaches, critical, psycinfo, outpatient assessments of patients, exploratory, additional studies, span, compensated hfpef, turnaround, candesartan, major underlying mechanism of hfpef, surgical indications, tube, mitochondrial structure, sport, principal discharge diagnosis, consecutive, support lvad use, amelioration, based practice, echocardiographic measures, collaboration among cardiologists, contemporary chronic heart failure, subsequent, dose of doxorubicin, von willebrand, doxorubicin-induced, lower natremia, defense mechanism, zsf1 rats, natriuretic peptide, kansas city cardiomyopathy questionnaire, pulmonary vascular resistance, principal, e, randomization group, reverse remodeling parameters, consensus, non-sudden, effect of follow-up, high-quality, older women, clinical trial, greater risk, international guidelines, use of angiotensin, degenerative mr, hospital quality of care outcomes, multihospital study, greater impact on patients, all-cause medical, writer, endopeptidase, human failing hearts, pulmonary vascular, lv end systolic volume index, alternatives, evaluation study, antagonizing excessive β-ar drive, limited value, non-aas, examined changes, phenotype, central glycosylated region, palliative care of patients, case-fatality rate, catheterisation, non-randomized, powerful independent predictor, robust, control group, included mortality, material, post-lvad, resuscitation, pairs, madit-crt trial, suppression, ventricular function, nyha, vascular disease, limited data, charm programme, reprogramming events, daily, fear, acute, prevented insulin action, right pulmonary artery, transduction pathways, low activity, serum, morphologically comparable, coverage, calf, modeling, 30-day rehospitalization, hospitalizations in patients, profile of paf, effects of care management, reticulum, cardiac washout, left bundle-branch block, length of follow-up, e'lateral, coming decades, pediatric heart, chronic advanced heart, sudden cardiac, prevention trial, lvads, tension, bcl-2 mrna expression, cardiopulmonary, longitudinal systolic strain, broader, elevated nt-probnp levels, irs2, oht in recipients, sarcopenic range muscle wasting, anabolic, interventions in heart, documentation, nt-probnp to age, interventricular, chronic acf, undergoing lvad implantation, 25th-75th, index beat method for cv events, randomized study of exercise training, change in type ii, increasing evidence points, inflammatory biomarkers, clinical, acute hf diagnosis, including fewer st-segment-elevation mis, multicenter study, myocardial extracellular matrix accumulation, practical, failure model, compensated, meta-analysis, context of hf, divided physicians, pulsatile, testosterone supplementation, human, measuring heart failure care, cooper, spearman correlations, cohorts, ecs, implantable cardioverter-defibrillator therapy, assess robot-assisted gait therapy, ann, nights, medical outcomes, epidemic, chronic hf, acute hf, measuring frailty, ejection time, training, neuro-hormonal, severe pulmonary, coronary artery bypass surgery, cardiovascular reserve, hospitalization for heart failure, fibrillation for stroke prevention trial, lvet at icu, outcomes of catheter ablation, mpsms, study closure, pressure-overload hypertrophy, baseline kccq scales, public reporting on quality aims, delivery of therapies, post-acute care transfer policy, foundation of management, smoking, mechanism of action, length, hf patient, dodson et al, transplants, randomized controlled feasibility study, alterations in energy metabolism, genes, higher rate of rehospitalization, cxl-1020, doxorubicin-induced heart failure in rats, phospholipase, nondiabetes risk factors, bnp in hf, skm, converts, non-hf populations, complex set of variables, medical records, smoking cessation, endoplasmic reticulum, prediction of lv reverse remodeling, heart magnetic resonance imaging, fontan adults versus controls, bottleneck stent model, red, unclear etiology, hospitalized heart failure, potent, mitochondrial-targeted peptide, vivo, first-in-man experience, prognostic relevance, pathological gene induction, final multivariate models, functional class iii, causal in hf pathogenesis, poc technology, ventricle in heart failure, medline, scn5a transcript, nonselective, select, uncontrolled hypertension, systolic strain, criterion standard, current guidelines, common syndrome, low testosterone status, guide, va health care systems, self-care of heart, mitral flow velocity, increased qtv, mr-proadm, papillary, kccq overall summary scores, guideline-recommended medications for patients, determined chf visit rates, women ≥65 years, hospital days, neprilysin inhibitor prodrug, pace, systematic monitoring of lvad use, recovery period, detect congenital accessory pathways, swedish national inpatient registry, szeto-schiller, epicatechin, eplerenone, anesthetized, ventricular ejection fractions, saxagliptin users, tgtetmena, heart failure-related qol, half, adequate self-management training of patients, icd, outcomes study, virtual, greater benefit, arterial tonometry, qrs, 90-day mortality, hypertrophic response, ambulatory setting, hypertensive heart disease, stable severe systolic hf, unique to patients, circumflex, early beneficial clinical, hospitals, comanagement, differential effect of lvef, geometry, e-wave, initial diagnosis of af, ncdr, characterize events, goal-directed, campbell collaboration, derivation cohort, cox regression models, higher serum levels of creatinine, adopting evidence-based practices, relative minimal detectable change, phosphodiesterase-2, twofold increase in lv, drug-untreated, downregulation processes, plane systolic excursion, immunoreactive, cox proportional hazards, safety monitoring, small retrospective studies, intl, major development, improving quality, moderate level of crf, echocardiography evaluations at baseline, management programs in heart failure, attenuating cardiac remodeling, inability, pluripotent, systemic, subjects, intact, anastomosis, echocardiography, management of end stage heart failure, youngest patients, equivalent adverse outcomes, speckle tracking echocardiography, fixed-rate atrial pacing, allocation, experimental evidence, current treatment, adipose, website, late-activated lateral wall, clinicians, systolic heart, specialized hf resources within health systems, healthy volunteers--a pilot study, longitudinal strain, risk of hf, shortened lvet, peak oxygen consumption, abrogate pathological gene expression, biopsies, high mortality, youngest age group, patients with heart failure, registry–medicare, adjusted hazard, 0·01, n-terminal pro-brain-type natriuretic peptide assessment, multivariable analysis, urea, tissue doppler early diastolic, beta-blocker therapy, contrast agent, behavior, cytotoxic, subsequent hf, infection, baseline ea, normal coronary arteries, cox regression, implantable cardiac defibrillator, eligibility, error of measurement, young normal reference, rate, examination of dna fragmentation, referral, compensatory hypertrophy, heart association, visit, stenotic, progressive development, forms of nt-probnp, lack of benefit, receptor blocker, mechanical cardiac support, metrics, susceptible, hf-related, province of québec, sustained, high confidence in estimates, artificial pulse, leu3-gly4, neonatal rat ventricular cardiomyocytes, gain, p38alpha mapk during insulin resistance, xo-mediated ros effects, worldwide increase in life expectancy, septal wall cs during avd variation, therapeutic approaches, underlying, kcl-ki treatment, terminologies, data, tailored follow-up, lipid-lowering, storm, effect on crt, median body mass index, lvet at icu admission, postnatal, normal geometry, activities, primary culprit, motions, greater reduction, antiarrhythmic, ste analysis, fluorescence resonance, care delivery, predicts clinical outcomes, development patient discharge data nonpublic, areas, economic, insignificant, heart failure patients with devices, noc, improving physician adherence, fontan adults, cardiomyopathy in patients, cardioprotective effect of nicorandil, extracorporeal membrane oxygenation as bridge, therapeutic approach, strategy, blood, hvad devices, obese zsf1, health characteristics, main etiologies of hf, levels ≥, tgf-β inhibition, sound, workload during stress, quick, 3-vessel cad, myxomas, nondiabetic patients, clinical practice, composite quality, global proteomics, outcomes in heart failure patients, chronic end-stage heart failure, kappa coefficient, analyze clinical outcomes, preoperative renal dysfunction, hypoalbuminemia before surgery, beneficial results, abnormal in individuals, cardiovascular risk factors on hf mortality, stenotic physiology, ongoing rhythm, health abc hf model, displaced papillary muscles, early-outgrowth colony-forming units, t2d, major safety measures, pacing period, metabolism, pasp relationship, respiratory, quadriceps, acute care surgery in heart transplant recipients, diastolic dysfunction in patients, current knowledge, nyha class, willebrand factor, mind, function in children, web of complicity, left atrium, adherence to prescribed, circumferential, connected elevated resistin levels, established preferences, mild heart, failure in rats, chelation, quantify changes, registries, major public health problem, sixty-one patients, testosterone status, receptor neprilysin inhibitor, twenty-seven, costs, mdc, frailty on hf risk, unfavorable outcome, ejection fraction, april, therapy refractory cardiogenic shock, hepatic, pathophysiological origin, cardiac magnetic resonance postcontrast t1 time, excessive secretion of arginine vasopressin, log-rank, capillary wedge, medical history, beneficial effects in chf, chronic, interactors, current practice, perfusion, primary isolated cabg, brachial systolic pressure, new york heart association functional class, male patients, tachypacing-induced hf, hallmark, terms, principal findings, rem, collateral growth, ang, québec health insurance board databases, exercise adherence, international classification, myocardial remodelling, colony-forming, rate-control group, income, cpgs, electrocardiographic, variants of genes, test-retest reliability, hungary, adjustment for age, enzyme inhibitor, improves autonomic balance, chf-nyha-iiib, programmes, nyha functional class iv, acetyl-lysine reader proteins, higher, anesthetized dogs, valvular regurgitation, chronic kidney disease, future hospital mortality, major right ventricle overload, board, nominal, walk, events in patients, discussion, two-vessel model, congestive heart failure patients in addition, functional ms, traditional heart failure, outpatients with heart failure, benefits of exercise, included markers, recovery, tone, reported greater risk, alterations, lower body mass index, trial results, toronto, cross-linking, pro2-leu3, health system, volume of patients, hretn, pharmacological armamentarium, lower von willebrand, positive effects, higher furosemide dose, inc, response, treating patients, conditional gene-targeted hand2 mice, reduced hospitalizations, inactive, t-score, targeting, valve tethering, refractory right heart failure, sympathetic outflow, ways, cerebral blood flow, ≥, department of cardiology, types of beta-blockers, rats, net, stable hfpef, open stent, immunoprecipitation, periodic, relaxation, nps, hfe, effective anti-neoplastic agent, aggressive, short follow-up, data in latin america, update, elderly male patients with chf, min after rehabilitation, self-rated, disease in patients, prespecified criteria, all-cause medical hospitalization in hf clinic, worldwide, chf after hct, assessed hyperkalemia, adjuvant, raloxifene, percentage points, history of angina, relation to sustainability, double-blind, eliminates, health care, actions, drugs, human-to-human contact, patients with cad, acute rv, beliefs, periodic breathing, feasible in heart failure patients, norepinephrine-induced, exercise attendance, ratio form, inhibitor, sex-specific, mets, cardiac overexpression of mammalian, responsiveness, plasma membrane, ulcers, anecdotal evidence, selected cardiac surgery patients, distinct subset of hfpef, thirteen, dissemination, ang ii, testing, prevent readmissions, prospective study, stand-alone diagnostic devices, parallel-group, beat-to-beat, cs, newer, caucasian, zung self-rated depression scores, autonomic imbalance, optimal combined treatment measure, lyso-paf-at, β-adrenergic receptor, coronary syndrome, insulin-stimulated rates of glycolysis, blockers, afterload of patients, months after ablation, time of surgery, adult patients with heart, effective across transplantation eligibility status, tapse, inconsistent, instance, β1ar downregulation, discussions, breath, functional capacity, messenger rna, kg, coronary artery bypass, markers, cardiac output, deliver specialised care, outflow, isolated heartmate, human ventricular systolic hf tissue samples, ablation, shuttle, migration, safety of catheter ablation, exercise programme, sudden, diastolic mitral valve, pasp increase during exercise, patients with ahf, arterial pressure, factors, score, unplanned admission, selected antihyperglycemic agents, fig, ppr, increase in patients, free-breathing, diagnosis of af, doses of β-blocker, direct observation, class ii heart failure, dxa, care program, dramatic induction of hretn, antihyperglycemic, marked cardiac insulin-resistance, hdl-bound malondialdehyde, post-myocardial infarction heart failure patients, tm during office hours, pulse-wave velocity, surgery, atrial area, peripheral muscles, wedge pressure, study drugs, visits, positron, relax-ahf, contractile function, c-index, ultrastructural, volume status, ste, cardiac vagal, rehospitalization, years old with heart failure, maximal systolic elastance, comorbidity, cardiac tissues, strength, shah, subsequent meta-analyses, rotations, comprising hospitalization, confidence intervals, increasing number, preliminary, oxygen pulse, disease phase, oxygen uptake, collagen deposition, emergency room practice, voltage-gated cardiac, aortic valve, distance, mi characteristics, first acute myocardial infarction in western australia, future ami mortality rates, intention-to-treat principle, guideline-recommended target dose, mi animals, months of treatment, main effect, fractional, pronto, deleterious effects, β2-receptor, non-urbanized, all-cause hospitalizations in patients, hf in non-aas, shotgun, developed cardiac apoptosis, facilitate individualized approaches, use of trastuzumab, diseased mouse heart, catecholamines, biologic, patient-operated, rural south dakota, alphalisa immunoassays, low-volume sites, augmented, ann arbor veterans, care transfer policy, conclusions, reduced mitochondrial complex, effective evidence-based therapies, cell expansion protocols, right-sided, regulatory subunit, preserved systolic function, buddy program, results of patients, determination, patients with ic, predicting 4-year survival, stroke volume index, hf patients, increase rehospitalization of medicare, telemonitoring, chronotropic, demonstrated reduced kd, dementia, resistance training intervention, large cohort study, time-varying covariates, measuring np levels, based, developed first-in-class inhibitor jq1, population-based study, time period, so-called end stage, ischemic-hypertensive cardiomyiopathy, thrombotic, pluripotency marker nanog, ventricular pacing, quantitative analysis, larger, users of bisphophonates, adenylyl cyclase, outcome, first hf, cost-effectiveness, multivariate logistic regression analysis, ii fontan adults, cancers, lessons, normalizing mena levels, baseline st2 level, danish heart failure, confer health benefits, duplicate, ca, contractile reserve in patients, followed-up, high-cost, absorption, total arterial compliance, range, current strategies, levels, standard care, estimating lv filling pressure, cpg, physician volume, december, enhance myocardial function, develop atherosclerosis, eventual, potassium, marked resistance, annulus velocity, radial, organization, artery bypass grafting, careful consideration, higher baseline, lower rate in patients, tactics, carvedilol, largest series of acs problems, st2, mri-based, outpatient models, total adiponectin, patient perceptions, l-type, improvement, current dietary recommendations for patients, β-blocker uptitrations, large limits of agreement, increased cardiac mrna levels, assays, rs, jq1, parasympathetic neurotransmission, ≥2, ischemic events, outline strategies, ventricle end-diastolic pressure, end diameter, delayed benefit, cytotoxic effect of doxorubicin, levels during lvad, left-hand, case-control analysis, county, network, cfi, peak o2 per kilogram, bioinformatic, ros, multicenter, computed, regulates cardiac sodium current, case of angiotensin, cardiomyocytes from human, reflecting marked decreases, end-stage renal disease in outpatients, describing trends, multivariable models, novel pure hno donor, ventricular-pulmonary, expressing human resistin, decreasing albumin levels, mitral filling, readmission rates, randomized controlled trial, refill compliance, citrate cycle, mi animals with metoprolol, willebrand, chronic myocardial ischemia, substitution, sham-innervated, unknown, noncardiovascular drugs, high-density lipoprotein functional properties, subjects without psoriasis, careful, dialysis-dependent patients with heart, myocardial dd of collagen deposition, cardiac failure, fluorescence, portal, circumference, anand et al, cation, protective effects of exercise training, nephrectomy, salt loading, categorization, acetylcholinesterase, improves exercise capacity, pump function, risk for hyperkalemia, blocker therapy, development, midregional proanp, predicting survival, levitated rotor, cardiac tissue from mice, plasma nps, link, examination, time interval, changes in body composition, rare in outpatients, perceived social support score, proteome of hdl particles, fes group, additional prospective, acute coronary syndrome, prevent cardiovascular complications, adjusted odds, health outcomes, patients from québec, endothelial dysfunction, scar size, low crf categories, exercise modality, patient population, heartware patients, principle, intervention, tracking, finding, lv systolic, cardiac hypertrophy in tta, chronic β-ar stimulation via catecholamine infusions, sitagliptin versus insulin, acute right heart, bradycardic, phase, younger than non-survivors, new chromatin subproteome, predict mortality, antagonists of endothelin, prevalent coronary heart disease, cα, anemia treatment in patients, tnf, skeletal, improvements in shuttle walk test, urine volume, echocardiograms, high crf categories, cardiac amyloidosis, change in cystatin c level, assist practitioners, early-outgrowth, ci, preserved ejection fraction outcomes trial, nuclear factor, main objective, multicenter automatic defibrillator implantation with cardiac resynchronization therapy, higher serum levels, tethering, factorial, crf categories, rad q66p limits, sudden cardiac death, depressed in acf, standard cardiac, malignant, receiver, longitudinal performance, computing readmissions, isolated heart rate, implant, variance, community perspective, modest conservation, heart failure index version, epicatechin-rich, tunel method, thromboembolic events in heart failure, chf atrial explants, ages, common elements, emergency, bodies, cardiomyopathies, log2, displaces bets, classification, thirty-seven, echocardiographic examination, body composition study, retention, age, arterial coupling, midwestern, phenotypes, implantations, respect, interventricular septum biopsies, heart failure risk, paradigms, york heart, prespecified, hypertrophy after transverse, presentation, concrete data, 6mwt, non-fatal stroke, population-based rotterdam study, first week, survival study, surface ecgs at baseline, ef≤, definition, invasive, sarcomere, carvedilol than metoprolol treatment, fit, new approach, intake, tobacco, dyspnea, obese men, β1ars, emphasis-hf, hospitalization in hf, embryonic, α-subunit, preserves, reflecting rapid r-r interval oscillations, swine model, slowed conduction, ies, ventilatory efficiency slope, insulin-stimulated, mechanical circulatory support, safety of chm, n2bus, trial of heart, strata of hospital volume, mrna levels, requiring isolated heartmate ii, annulus, meaning, version, correlation to changes, mediated reduction, future mortality, detectable, combining salt loading, subproteome, dysfunction, treatment of hf, ischemic hf pathogenesis, catheterization, hfpef, zsf1, failing, prognosis, aha, cardiovascular events for psoriasis, vivo coronary perfusion, risk for hospitalized heart failure, implementation issues, device, joanna, esc advocate pre-participation screening, lower among patients, training in patients, decreased mitochondrial energy production, provide information, failure risk, potential contribution of poc measurement, modestly lower, left ventricular ejection fractions, tissuefaxs technology, valve opening, histologic, new york heart association classes, effectors, attributable to titin hypophosphorylation, non-survivors, r-r, identify benefit, relative value of mdc, stay, filling time, study-a multicenter, hf clinic outpatients, transfer policy, improved time, cross, mechanical dyssynchrony, cardiovascular outcomes, healthy age-matched, negative binomial regression models, intention-to-treat, turkey, histone, ivabradine-treated, extracorporeal support, haemodynamic stress, plasticity, examined characteristics, phenylephrine-induced, common applications of readmission metrics, stressors, treatment for heart, medical hospitalization in hf clinic, hf, non-dilated, right atrium, ≤, ai, special, frail, pump failure, biomarker-guided, young adults, left ventricular hypertrophy, post-tac cardiac functional deterioration, 2-year study period, excessive, facilitate documentation, halts heart failure, intermediate frailty, cms, left ventricular dd, g-protein-coupled, systems, early diastolic, non-urbanized midwestern state like south dakota, outcome measures, considerable, low-quality, transgenic, hemodynamic, risks of hospitalization, adverse neurohormonal activation, lipoprotein-associated phospholipase a2, subgroup analysis of patients, cardiac transplantation, reverse, ii heart failure, data synthesis, re-express, fontan failure, subjects with heart failure, p38, clear evidence, evaluate mortality, physician continuity on death, prescribing, management interventions, process redesign, generated heart-specific irs1, osteomedullary biopsy, instability, valid measure of patients, month follow-up, 6-mwt, young, australia, treatment with ivabradine, crt-d recipients, progression to heart failure, validity, oral, medication regimen, adjusted carotid intima-media thickness, admission median bnp levels, caspase-3, circulating cd34, religious beliefs, multiparametric echocardiographic score, management interventions in heart, hallmark feature, stenosis, effector, acute rv failure, receiving chemotherapy, electromechanical, anoop, steady improvement in egfr, two-vessel, pathological heart disease, optimal, excluded patients, additional, crude, tug test, laboratory report, quarterly inpatient admissions from baseline, ischemic heart failure samples, acetyltransferase, modifiable risk factors, provide support, dd, province of alberta, sinus rhythm at follow-up, ed cases, systems proteomics, genuine, analyzer, simple experimental procedures, refill, extra corporeal membrane oxygenation, glomerular, median bnp level, hf pathogenesis, poor myocardial function, interatrial shunt, myocarditis, antecedent, partial reversal of changes, mi-induced decreases, atropine, secondary end, world health, 10-cell decrease, prevent adverse outcomes, evaluated temporal trends, predominately male, undergoing anthracycline-containing chemotherapy, conjunction, full-length, modern society, afterload, hg, country, severe systolic, inducible, muscle mass, lower gross national income per capita, centrifugal-flow, atp production rates, clinical variables, assisted, msec, simpler, amenable, lv hypertrophy, doses, early deaths, serum albumin levels, cardioverter-defibrillator deactivation, precapillary pulmonary hypertension, conjoint, sitagliptin users, chromatin-mediated, citations, accurate, nri, multicenter automatic defibrillator implantation with cardiac, provided self-care education, nitroxyl, clinical benefit, accompany heart failure, humoral, stage, enormous, health organization, clinical characteristics, bb at enrollment, elevated cardiac filling pressures, hdl-mediated protective effects, creating uncertainty, hypo-response, carbohydrates, diuretic use, computational study, reduced clinic, safety of rhythm control therapy, cachectic, systolic dysfunction treatment, ra population, congestive, ang ii infusion mouse model, paf, destination therapy, clinician, anticoagulants, development of heart, necrosis, enhanced pde2 expression, lower event rate, onset of heart failure, undergone randomization, nurse assessment, lack, on, treatment of anemia, chronic pah, quarterly, complementary, study group, systolic volume, maximal cardiopulmonary exercise test, observational cohort study, overweight, anthracycline, assignment to ecct, asymptomatic, biomarker-guided clinical, tta, investigation of apoptosis, survivors of childhood, nicorandil, methods, notable, new-onset esrd, occluded, features, isoelectric, wave ratio, patient preferences, healthy individuals, late-onset, outcome ratings, improves diastolic function, resistin levels, breakdown, advances in treatment, randomised-controlled, cxl-1020 converts, release, exercise testing, kaplan-meier curves, ® immunoassays, ®, pure epicatechin, process, chf, action potential duration, patients with non-lbbb, splicing, novel heart failure mice model, novel porcine model, dosages, patch, hospital characteristics, end-of-life, intact hearts, elastance, quality of lv dysfunction, promising field of investigation, natremia, acute myocardial, use of biomarkers, murmurs, individual quality measures, life-threatening situation, small trial of patients, ventricular filling pressure, overweight body mass index strata, absence, diagnostic role, excellence, developmental chromatin remodeling events, scaffold protein, reduced peak oxygen uptake, shock, level of agreement, physicians into quintiles, reduced lv contractility, treatment options, bundle, actin cytoskeleton pathways, current status of np measurement, higher pasp, substantial improvement in survival, chf-inv, rna polymerase ii, doppler ultrasonography, ring, heartware, radial strain, reduce morbidity, recommend cardiac resynchronization therapy, decrease co, dietary, unfamiliar physician, substantial subset, implantation with cardiac resynchronization, effective practice, 43-47, constant, optimal combined treatment, neuronal stressors, severe pulmonary hypertension, seattle heart failure model, enrollment, ecmo, proof-of-principle cohort, time-dependent variable, clinical outcomes, primary outcome, improves outcomes, electron microscopy, trastuzumab-treated patients, patient-operated electrocardiographic device, contribution of nursing, odds of future, weight loss, antiplatelet agents in combination, hypothesis, yield, study short-form, va-rt, nucleotides contents in addition, repeated measures, dash diet score, improvement in 6-minute, albumin level, implicates epigenetic readers, 41-year-old, anti-oxidant, regimens, dna fragmentation, resynchronization, filling, states, pdrelated, greater self-reported physical activity, programs in heart failure, overwhelming, implantation with cardiac, regional, future perspectives, consequence, statistical model, multisite studies in practice settings, males, flutter, key biosynthetic enzymes, participation of apoptosis, jersey, actin cytoskeleton, plasma of heart failure patients, battery, reduced ef, efficacious, ed visits, calcium, reduced ejection, overload, variations, blot, reserve in patients, adipokines, dilation, insights from heart failure, muscle-wasting syndrome, mineralocorticoid, extracellular matrix to fpassive, underwent echo-doppler studies, aldosterone antagonist, scar, intravenous atropine, obstruction, sepsis, associations of hhf, existing measures, tunel-positive, repairs, twenty-one rcts, wk, first-in-class, key adverse events, assisted success rate, propensity-score matched control group, purely hemodynamic, explore interactions, quality-adjusted survival, left, chelation choices, pf cohort, higher scores, fragmentation, kinase, diagnostic procedure, annuloplasty, preserved phosphocreatine, efficacy of eplerenone, channel mrnas, california office of statewide health planning, wall stress, marked reduction, coprimary, intervention compliance, antiplatelet, site-specific monoclonal antibodies, role, 4-5 wk, heart failure cost-effectiveness model, rate reduction, attenuation, heart failure development, heart, patients with new york heart association class iii, atheromatous coronary disease, influences, aspects, drug-free, sarcoplasmic, saxagliptin versus sulfonylureas, simulation models, patient-level, low-volume institutions, regulation of feeding, surviving left ventricle, growth factor beta-dependent yield, clinical tool, contextual factors on physician adherence, insight, motivate hospitals, tug, vasodilator effects in vivo, new systematic review, mitochondrial-targeted antioxidant, effects of treatment, annular plane, b natriuretic peptides, titin, temporary centrimag rvad, crt, varying combinations, hospital days for participants, special therapeutic interventions, rate-control strategies, choice, nuclear, twofold increase, cochrane, feasibility, hospital between january, pro-brain-type, histological, hfpef patients, svr, reciprocal downregulation influences, staff, general use of beta-blockers, succinate, canadian, order, sternal, accumulation, rotterdam study, passive, beta-adrenergic receptor, right ventricular ejection fraction, dramatic improvement, problems, cardiac magnetic, electromechanics, tidal respiration, exercise per week, repolarization, regression analysis, three-year hf hospitalization rates, uncertainty, randomized aldactone evaluation study, calculate hazard ratios, senescence, eh, coefficient, cohort analysis, valid approach, chagas, vascular endothelial growth, inotropic, acute kidney, including medline, enzymes, lowest cumulative hazard, objective criteriabased institution, arni, construct, ≤90, direct, aims, hemodynamic alterations, content-driven, intubation rates, study breathing control, developed heart, myocardial phosphodiesterase-2, systematic review, secondary study end point, icu, embryonic gene programs, adults with heart disease, services, l-type channel inhibition by rgk proteins, unique to rv failure management, flow, beneficial, cardiac growth, lv ef, identified patients, therapy with saxagliptin, antihypertensive, predictive value for heart failure, signed-rank, kir, hand2-dependent manner, global gene expression, undergoing renal dnx, mild restriction, vascular stiffness, obese older patients, heart transplant, volunteers--a, possibility, general population, novel mouse hf model of hhd, israel, atypical, box, potentials, sham explants, transcript, equally effective, study sites, elevations, pol ii, anova with differences, amino-terminal pro-b-type, pevk, mortality in icd-hf patients, monitoring, years of follow-up, patients hospitalization, electrical activation, procedural, implantable cardioverter-defibrillator deactivation discussions, laboratory, cd34, inappropriate implantable cardioverter-defibrillator therapy, devices, discordant, aetiologies, inducing hyperkalemia, high-volume, fundamental mechanism, lvad use, echocardiographic systolic parameters, nursing-sensitive outcome change scores, 6-month echocardiograms, event rate, β, efficacy, ecct, end-stage, full length nt-probnp molecule, conditioning, ingenuity, alterations in markers, cochrane databases, promotes restoration, perturbations, stretch rate, renal dysfunction, albumin, pressure, contractile response, aware, bone morphogenetic protein, city of hope, improving hf prediction, centre for reviews, ser96, exerts endothelial-protective effects, patients with new york heart association, overexpress, patients in new york heart association, pcwp, measured baseline, serum cystatin c from enrollment, enhancing medical management, posterior, users of bisphosphonates, distribution, providers, average hospital rates for hf patients, right atrial myxoma, n-terminal pro-brain, death in patients, changes in rs synchrony, benign, pilot program, lv internal diameter, prognostic factors at admission, egfr group iii, ra, coronary perfusion, sixteen new york heart association class i, median rate, limited maximal cpet, hart, cell yield, cardiac gene control, ventricular diastolic, multivariate analysis, conjoint education, pulmonary arterial systolic pressure, required heartmate ii insertion, biomedical treatment, sts interventions, lad model, sensitive measure, lower rates, general linear models, tachycardia-induced heart failure, organ, respective age categories, clinical data, adherence to prescribed therapy, exhibited higher risk, countries, evidence-based care, coral, consultation, efforts, subdomains, discharges, titin modification, articles, failing interventions, cystatin c level, demonstrated superior reverse remodeling, likelihood, condition, outcomes in heart, bundle branch, occurrence of hf, sequential phosphorylation, chromatin subproteome, chf-nyha-iii, advanced heart failure therapy, leukocytes of participants, low systemic vascular resistance, heart failure discharges, highest quartile of e, implantable cardioverter defibrillators, failure nurse, surgical revascularization, heart failure with preserved ejection fraction, addition, iii to class, modified seattle heart failure model, mapk, primary oscillations, mid lad, improve quality, exertional shortness of breath, first-in-man, 3-month survival, left heart twist, univariate analysis, emergency department, habc, uneventful recovery, decrement, intravenous, college, swine with heart failure, patient management interventions in heart, risk stratification, cognitive impairment, fixed ring size, referent, elderly people, allogeneic, higher furosemide, use, rate-control patients, hf risk factors, radial artery tonometry variables, sufficient, future trials, heart failure disease management programs, units, long-term continuity of care, natriuretic peptide system, lower von, new therapeutic targets for hhd, anemia in hf, pediatric cohort, outcomes trial, elateral, establishment, clinical status hospitalizations, stabilized chronic heart failure, artery disease, decompensated systolic heart failure, reduce cardiovascular complications, initiated spironolactone, chromatin hyperacetylation, materials, 60s with new york heart association class iii heart failure, two-center pilot project, terminal phase, hdl-induced, chf-developed infarcted animals, progressive, healthcare common procedure coding system, failure index version, mechanistic, poc systems, transitions of care, ambulatory patients with heart failure, evidence of diastolic dysfunction, tract, randomized trials, end-stage heart failure, thr197, elderly patients, simple, interaction term analysis, side effects, hemolysis events, kidney index, centres, neuronal, molecular, signaling, abcc2, event, twenty-one, women vs men, strong reliable mortality predictors in icd-hf patients, health buddy, healthcare, angina, 6-minute, remote ischemic conditioning for patients, therapy in heart failure, higher serum levels of brain, cell-derived, measuring hospital, initial approach, efficacy in vivo, guide treatment, icd patients, parameters in patients, phenylephrine, central venous pressure, ehrlich, start, specificity for cad, interaction terms, implicate resistin, congestive heart, apparent concentration, diagnostic test, oxidative, serum resistin levels in women, 12-week program of exercise, cumulative anthracycline exposure, logistic regression models, in-hospital adverse events, large registry, ciaraldi, myocardium, endothelial cell, york heart association class iii, cross talk, left bundle branch block, explant-derived progenitor cells, metabolic risk factors, providing guideline-recommended care, changes in co, exercise capacity in adults, rounds, procedure-related major adverse neurological, functional class iii hf, sudden cardiac deaths, negative likelihood ratio, article by dodson et al, indicative, double mutant, hope, 30-day readmission rate, adjusted, cardiopulmonary exercise testing guide, life in patients, largest, standard heart failure medicines, post hoc analysis, autonomic nervous, hearts of fish, receiving ecmo, result of shortcomings, ambulatory, diastolic mitral annular velocity, technical, l-type channel-dependent processes, prognostic significance of bnp, japanese heart failure patients, paf-ah, psychometric, infrequent, transition markers, bb therapy, drs, increase mortality, maximum, therapeutic, chart review, insignificant ms, single-institution, anterior leaflet, constructed additional models, higher risk of death, 3-year, adverse health outcomes, affairs hf, essential, calf muscle, urban academic medical center, relation, abnormal scn5a mrna splicing, doxorubicin in rats, width, logistic, nordic walking in patients, barrier, dt, relationship between tapse, bromodomain-containing, reclassification of risk, congestive heart failure trial, flow-mediated dilatation improvement by et, kappa, eliminated cardiac hypertrophy, neutral, feasible alternative, end-stage hf, heartmate ii lvad, prescribing guideline-recommended medications, gastrointestinal bleeding, outpatient setting, muscle strength, pigs, haematopoietic, epifluorescence, ka renal chloride channel gene, heart failure samples, protective role of s1pr1, pulmonary artery, functional mitral, minutes of exercise, rvpo with bivp, buddy, ensure effective practice, treatment strategies, fatal, heart failure index, anaerobic, standardized exercise protocol, initial, enhanced, outpatients with hf, longer, renal artery, limits, concepts, defense, inhibitors, kccq category among patients, independent predictor, intraclass correlation coefficient, chemotherapy-induced, control model, hvad, hyperacetylation, experiencing heart failure, iron deficiency in adult patients, early physician follow-up, emission, future, ed physicians, patient management interventions in heart failure cost-effectiveness model, rv length-force relationship, key health outcomes, care system, maximal ventricular power index, molecule, receptor neprilysin, mrna splicing, high bnp, guide health service planning, serum potassium, isoforms, nucleolin, control adenovirus, automatic defibrillator implantation with cardiac resynchronization, ffm, gln27, anthracycline-treated, predicting death, beck depression, additional benefit, ch, change in lvet, oxidation, bhlh transcription factor, depressed left ventricular, protection, nationwide, provide long-term support, noc outcomes, aldactone evaluation, chm, inoperable, inotropic effect, median follow-up duration, conventional clinical, worse heart, time, focus of research investigations, sustainability, chromatin-dependent, ventricles, aerobic, regular, aerobic exercise, pacemaker, augmented cardiac vagal, intravenous bolus of metoprolol, c-terminally, vascular endothelial growth factor, absolute value, moderate-strength, outcomes after adjustment, dual-energy, angiogenesis, hfpsi model, rationale, 7508t→a, b-type, derivation, number of patients, hospitalization in hf clinic, twofold increase in lung weight, typically exertional, continuous nris, non-frail, ng, proteolysis, practice-level variation, l-dko mice, functional efficacy, therapeutic interruption, uptitration, congestive symptoms in patients, clinical setting, cardiac autonomic balance in chf, standard error, growing population, re-activating transcription, pulseless ventricular fibrillation, complete coronary occlusion, chemical instability, considerations, persistent, medicaid services, metabolic, propranolol, optimal diuretic therapy, hypertension patients, adenoviral vector, lv strain rate at diastole, dilated cardiomyopathy cohort, july, coronary heart disease, sa, healthy control animals, interventricular delay, readmission metrics, biomarker, mineralocorticoid receptor antagonists, venous, deterioration, clinical status, strips, sv, excitation-contraction, practice-level, injury, orchestrate genomic, vegf inhibition, czech republic, bnp levels, exerted dose-related benefits, autonomic modulation of repolarization instability, mitochondrial ultrastructural changes, stable body weight in cc, dosage, edge, basal rotations, high risk, feet, scn5a variants with angii, dysbalance, signs of hf, investigating outcomes, bat, databases, hospitalization for heart, caloric restriction, kappa coefficients, proportion of deficits, esc, matched controls, heart failure patient severity index, gene expression of bax, circulation of hf patients, hemocompatibility, counseling, subset, ambulatory heart failure, cvd, partial pressure, annular size, intensive, contracting ventricles, high-risk patient, implantable cardioverter-defibrillator deactivation, prolonged, volume, worsening heart, ambulatory patients with hf, combined treatment, internal, society, produces beneficial effects, hf risk prediction, highly predictive, medicine, ef differences in bnp values, reducing mortality, st-segment-elevation, database, new, sdqt, received uptitration, four-week, systolic function, breathlessness, lcx, chronic obstructive pulmonary disease, physician adherence to hf cpgs, underwent cardiopulmonary exercise testing, healthcare staff, oral glucocorticoids, documented contraindications, activation of p38, cardiovascular events in patients, institution, yields relaxation, lcz696, skeletal muscle mass t-score, cardiac function among patients, progression to heart, myocardial tissues, charm, continuous relationship between qrs duration, heartware intl, linear mixed models, increased cardiac angiogenesis, care systems, long-term survival in ed patients, immunoassays, lifesciences, angiotensin-converting, cardiac sympathovagal balance, high risk for hyperkalemia, atp, higher risk, nanomolar, matched control, cpr, flux, american college of cardiology, sheet orientation, systematic review protocol, republic, strongest for internists, s12884, pharmacologic, identify patients, simulation results, soluble st2, bb, cardiac-resynchronization therapy, methotrexate, universal, favorable adverse event profile, forms, severe ischemia after bottleneck stenting, diseases, modulates, stent occlusion, window, disease severity, data on study design, lv fractional shortening, instrumented new zealand white rabbits, nt-probnp in patients, aa, vad groups, acute right heart failure with therapy refractory, higher btes, right heart failure, pairwise, multiple procedures, awful, right atrium mass, driveline infection, failure-related, transverse aortic constriction, pressure-overload-induced heart failure, accurate risk stratification of patient, propose fundamental definitions, clinical course, interval, average, transmitral e-wave, evaluating implementation interventions, viable option, resonance postcontrast t1, surgery by echocardiography, tools for economic analysis, good, transfusions, participant contact before august, patients with new york, cv events, long-term support to patients, pasp, subclass, favour of apoptosis, elevated, disturbed intestinal barrier, 0-105, older adults, risk for hhf, survival, angioplasty, east, leaflet, scale, animals with heart failure, debate, 60s, risk factor, technical advisors, exhibit, effective arterial elastance, prevention of hf, performed confirmatory factor analysis, va-rt cohorts, health-related, control without exercise, hybrid, crossover, fiber, evaluated associations, pre-specified analysis of subgroups, patient management interventions in heart failure, shunting, post-acute care, precapillary, chromatin, applicable, magnetic resonance postcontrast, vvd variation, right ventricular, well-recognised risk factor, aortic blood, functional etiology of mr, physical activity, college of physicians, creatine kinase activity, evaluated sts, candidate, endpoints, high muscle, intervention post study, atrial fibrillation, o2 per kilogram, potential effectiveness, receptor kinase-2, improve cardiac functions, completed surveys, vvd variations, urgent, strict statistical standards in biomarker studies, mild, endothelial growth factor, hhf, echocardiographic score, iron-deficient, ventricular wall stress, excursion, levels of plasma, parasympathetic tone by pyridostigmine prevents, non-ischemic heart failure samples, rates of energy substrate metabolism, modifiable, elevated bnp, impact of qrs morphology, primary study, avp, databases of medline, increase in exercise capacity, acute heart failure trials, capacity, point-of-care, left ventricular filling, perceived benefit, hospitalized older adults, direct effects on macrophages, wave, narrow qrs complex, value for age-by-lvef interaction, all-cause medical hospitalization in hf, orthotopic, diverse aspects, sprague-dawley rats, workload, hazard, exercise capacity, property, sodium-restricted dietary approaches, 10-year, kansas city cardiomyopathy questionnaire summary, population, ed patients, functional decline, concurrent, progress, perk inhibition, mineralocorticoid receptor, management of heart, controlled randomized trials, role in downregulation, targets of bets, function in hfpef, dynamic, fibrillation for stroke, derived absolute improvements, internists, peripheral abnormalities, differential g-protein coupling, programs in heart, pde2 overexpression, abnormalities, québec health insurance board, cfa, gg, interruption, r-like, efficiency, 30-day all-cause readmissions, received trastuzumab, enzyme, sarcopenic, external validity, sensitive, maintenance, acceptable to patients, fraction ≤, quasi-experiment, acute care hospital for hf, mitochondrial, processes of care, channel mrna splice variants, fragments, pulmonary embolectomy, transverse, prognostic value, medical management, amino-terminal, beneficial adaptation, improves skm, associations between new york heart association class, declined participation, cardiac transplant, stroke prevention trial, examine clinical circumstances, forty-six patients, transseptal catheterisation with transoesophageal, channel-dependent, clinical change, acute β-ar, lad models, admissions per patient, pulmonary capillary wedge pressure, report, majority, clinical follow-up of heart failure, adults with heart, matching donors, stand-alone, therapeutic potential, social, bisphosphonate users, routine, drug administration, end-diastolic volume index, echocardiographic, intriguingly, co-activating transcription factor networks, excellent fit indices, quintile, secondary outcomes, capita, lvh, high pasp, ahf, city cardiomyopathy questionnaire, stable severe, underwent standard criteria, ventricular action, cochrane effective practice, clinical doppler echocardiography, elevated levels of plasma catecholamines, autopsy samples, ischemic, contact, diabetes mellitus, disposition of at-risk patients, developed countries, irs2 proteins, la countries, life score, left ventricular ejection, analysis of doppler, family, postcontrast, strong predictors of mortality, rate-control treatment strategies, individual component, echocardiographic score for prediction, β-ar stimulation, single tertiary referral centre, short-term fractal scaling exponent, etidronate, outcomes for patients, main effects analysis, beta-dependent, equitable, african, micronutrients, improving survival rates, separate cox regression, unplanned, undecided, endothelial growth, glu27, perk, 6-month survival rates, declines, risk-adjusted mortality, symptoms of anxiety, cardiovascular system, exercise with placebo group, major public health, net reclassification, parasympathetic function, observational, chf patients, ventricular filling in patients, shorter, cardiopulmonary exercise, dietary sodium restriction, fiber shortening, preventive measures, differential effect, safe, qrs width, post-myocardial infarction, pacing-induced chf, inflammation-stimulated, stent, moderate reduction in lvef, organ failure, vasopeptidase, lv end-diastolic pressure, increase long-term survival rates, class, urgent readmission after discharge, brief, affect sst2 concentrations, cabg, specialised, myocardial perfusion, kd, development patient discharge data nonpublic file, body fat distribution, sarcomeric, titin isoforms, length-force, pro-adrenomedullin, ventricular tachycardia, telephone calls, annual ed visits for chf, utilization, economic analysis of patient management interventions, peak vo2, trastuzumab-treated, proteome, myocyte-specific, confirmatory diagnostic tests, clinical application, natriuretic, york heart association class ii, medicines, asymptomatic pediatric fontan, postmarketing trials, major adverse, glu27 haplotype, retrospective cohort study, deleterious β1ar overstimulation in heart failure, single-center, 5-year, shortens, dipeptidyl, new york, pre-defined inclusion criteria, thromboembolic events, posterior wall infarction, agent, connection, clinically stable, proteomics, improves co, topics of debate, correction, young adults with hf, ventricular end-diastolic, transplantation to consultation, wide, kg body mass, young adults with heart, et of chf-nyha-iiib, number of studies, circumferential shortening, weeks rapid right ventricular pacing, inpatient admissions, diuretic response, interaction effect, interatrial, partners, isoenzymes, poc, risk-standardized, catheter-based, typical amyloidotic pattern, legal majority, myofibrillar, hospital stay, dose-related gradient of hf risk, end, new users, duration on outcomes, intracellular, obese older, recurrent hf, inappropriate therapy in heart failure patients, synthase activation, experimental, candidate genes, skm mitochondrial structure, fig 1a, hyponatremia, movement, adverse outcome, novo, fes warrants, relevance, composite quality measure for heart failure, including t1 mapping, nutrition, sympathetic activity, year for heart failure, ratio of phosphocreatine, brd4, rehabilitation, plasma membrane translocation of glucose transporter, national, improved clinical outcomes, terms of recruitment, improved hdl function, early treatment, post-pd initiation, requiring temporary rv support, users of alendronate, supporting patients, skm biopsies, america, reduction in patients, improves tac, blots, standard therapy, zsf1 group, rise in camp levels, comparable, world health organization, including implanted monitoring devices, ascending phase, kccq domains, transitions of care program, tachycardia, independent prognostic, analyze interview data, main, modification of diet, restrictive red blood cell transfusion strategy, o-1, care in heart disease, treadmill testing, volume index, standard clinical practice, limited, e'mean, 2·9, transition, protocol-driven poc testing of np, activation of vegf, ion channelopathies, incidence in mt, including hypertension, effect of crt, patients for ras, nt-pro bnp, increased lv diastolic, arterial hypertension, compelling, practitioner, parasympathetic tone, abstract, oxygen flow, resistant hypertension, optimal medical management, transplantation, ® system, age-by-lvef, perkins, kaplan-meier, failure survey, difference between numbers, derangement, primary diagnosis, validation, targeting individuals, myocardial ischaemia, failure disease management, herbal, implementation, sub-sample, preoperative hypoalbuminemia, paediatric heart failure, interval from consultation, osteoporosis, heart magnetic resonance imaging on chelation, worsening heart failure, hrv, excellent prognostic ability, open-label, end-stage renal disease, extensive, systemic blood pressure, patient satisfaction, stress doppler echocardiography, anemia in patients, credible, categories of actin cytoskeleton, covariate adjustment, protocol, quality measure, beta blockers on exercise capacity, advocate, patients with dcm, stable cad, heart beat, heart failure-related mortality, nyha functional, transfusion requirements, vital, measure aspects, prediction of lv reverse, penalties, tissue, remote, multivariate cox, hypertrophied heart, reversibility, physio ring, simulations, co2, received transplants, components, sweden, robot-assisted gait, coprimary outcome, developed heart failure, presents guidelines, examined physician volume, surgical correction, angiotensin receptor blockers therapy, placebo-treated patients, high muscle strip, patient outcomes, hf during hospitalization, impact of ejection fraction, difference in outcome ratings, n-terminal pro-b-type, estimated glomerular filtration rate, va, colon, life-sustaining, motion, epicatechin-rich cocoa, high ≥50, western society, automatic defibrillator, final, heart failure admission, chromatin-dependent signal transduction, ethics, focus, cell differentiation, contribution, renal, requiring surgery, quality improvement database, symptomatic, heart failure patients, corp, protective, phosphocreatine, networks, explaining variation, publications, benefits, predicted values, ≤35, collected preliminary data, tidal, depressive, mlhf total score with exercise, patients with heart failure home, chronic hfpef, intervals, reduction in blood pressure, medical resources, lower fat, program of exercise rehabilitation, self-identified, c termini, cornerstone, delineated, rheumatoid, pulmonary disease, study end point, tgf-β, treat rheumatoid arthritis, comorbidities, apical, valvular disease, basic, science, xanthine oxidase inhibition preserves, trigger hemoglobin threshold, ± 16-month follow-up period, small noncoding rnas, nitric oxide donors, co-primary outcome, unsuccessful, invasive alternatives, end-systolic volume, exercise training in patients, correlation, early transmitral, 6-month, sensitivity, definition of hfpef, factorial trial, efficacy outcomes, assessors, incremental, larger randomized control studies, mechanisms of disease, postischemic heart failure, large-scale, profiling, signalling pathway, large-scale randomised studies, viscoelastic, β-myosin, optimize quality, helix-loop-helix, proangiogenic, 7-day follow-up visits, exhibited altered expression, iron-deficient adult patients with heart disease, nosignificant, disease management programs, population characteristics, morpholino-based knockdown of nucleolin, individual measures, identify clinical variables, narrow, participants, subspecialty, biological, maximal, unadjusted practice-level prescription rates, nanomolar doses of jq1, chronic disease, web-based program, fatty acids, first-ever, lad, tools for risk stratification, iii hf, hazard ratios for log2 ng, inpatient records of patients, idiopathic-dilated, involvement, cad, redo sternotomy, pharmacologic studies of therapeutics, vasodilators, shuttle walk test, systolic mitral annulus velocity, non-linear, effect on quality, oxidative stress markers, indications for lvas support, accountable, diverse, resonance, universal definition, performance measurement systems, dobutamine, evident, trend for improvement, longitudinal study, syndrome, indistinct, serial evaluation, g-protein-coupled receptor kinase-2, projections of resource use, optimal nt-probnp cutoff point, time to death, decreases in lv, cms metric, requiring biventricular support, protein content for sr, proteomic, association class ii, index ≤, nonmitochondrial protein changes, failing heart, wild-type rad, medical, cardiac angiogenesis, impact of qrs, dietary interventions in heart failure patients, patients with heart, ecg, cardiography, clinical prediction rule, administration, etiologies, hierarchical, monocytes, apoptotic cells, cell phenotype, contractility, rcts, lv structure, long-term mortality, baseline in peak oxygen uptake, postexercise phosphocreatine resynthesis, right ventricular fractional area change, sr, vascular resistance, language, transcription, clinical prediction, approach for heartmate ii exchange, symptomatic chronic, compliance, prior hf hospitalisations, postischemic, simultaneous, multivariate cox model analysis, 20-week time span, sub-groups, framingham, increased workload, use of antibodies, lesion, min in peak vo2, evidence points to alterations, quality, morphological, aspects of nursing care, neprilysin inhibition, real progress, inverse correlation, biological phenotype, increase in 30-day, cardiac arrest in humans, resection, increase in ejection fraction, 57±22 months of follow-up, poor outcomes, interaction, 3-vessel, including intravenous inotropes, generator, conscious rabbits, long-term complications, pairwise comparisons, higher levels, joint effect, mt, multivariate-adjusted odds ratio, haemodynamic, suburban hospitals in new jersey, inhibits l-type currents, improving processes, profound, arterial tonometry study, receiving implantable cardioverter defibrillator-crt, potential preventable readmission, bnp in hf patients, concomitant downregulation, future prospective experimental research, assist, role for micrornas, increased systolic blood pressure, patients ≤75 years, elevated left atrial pressure, hemodynamic perturbations, carotid, high risk of hyperkalemia, medical treatment for heart failure, increased sdqt, presentations, conventional, coronary artery disease in patients, contextual factors, admissions, isolated heart, reticular, nursing actions, normal sized lv, early transmitral blood flow velocity over tissue doppler, chronic kidney, awful paradox, provide consensus, vasopressin receptor antagonist, pump malfunctions, hospital longitudinal change, ventricular dilatation, mt group, index admission, old, pro6-gly7, correlation between performance, prognostic factor in heart failure, packages, setting of disease recapitulates, baroreflex sensitivity, variation, multivariable adjustment, inappropriate atp, small subgroup of children, underwent crt implantation, beta blockers, aas, clinical trials, cardiac pathophysiology, beneficial effect of exercise, high-cost medicare fee-for-service beneficiaries, unit increase, contemporary therapeutic options, redo, acute pulmonary embolism, dual, higher pde2 activity, levels during lvad support, vvd, baroreflex activation, peptide, causal, readmission rate, dialysis patients, improving outcomes, independent predictors of mortality, index of qtv, presence, 0·69, short-form, independent prognostic role in hf, familiar physician, university, rabbits, association with outcomes, bet bromodomain-containing protein, chf than nontrastuzumab, long-term survival, relative risk, clinical trial registries, guanosine, inappropriate implantable, tac, configurations, hospitalisations, transverse aortic, common type, rat metabolic risk model, micrornas, cardioversions, bpm, multivariate-adjusted, oscillations, psychometric testing, increasing refill compliance, alive from hospital, self-management counseling, male mice, processing, normal systolic ventricular function, goal-directed lipid-lowering therapy, groups, cent, nt-probnp, mitochondrial function, lowest cardiovascular event rate, central end-systolic pressure, greater risk of heart failure, multimarker-based, side, findings, vascular endothelial, ratio of peak, hypotension, pressure-volume, uneventful, extraction, therapy in heart, low bp, aldactone, antitumor, routine np assessment of ed patients, feasible und, guideline-recommended medications, women with heart failure, wrf, healthy heart muscle cells, non-aa, combined care management, purpose, declines in early-onset, highest cardiovascular event rate, stress, physical examination, combined end, published techniques, enhanced catabolism, fragments of nt-probnp, hall, hf in hhd, ninth, vegetables, heart failure care by 30-day readmission, discontinuation, high-strength evidence, talk, tachycardic response, arrest, disappearance of mr, ivc occlusion, beneficial trends, mice via phenylephrine, composite end, patients, reliable measure of health status, right ventricular contractile reserve in patients, lower during carvedilol, including anticoagulation, provider, acute care surgery, major parameter, lower exercise time, mri-based models, cardiac magnetic resonance postcontrast t1, preserved ejection fraction, heart failure survey, onset heart failure, electrocardiogram, genetic, meta-analyses, exploratory factor analysis, signifies repolarization lability, threshold, oxidative phosphorylation capacity, current amplitude, specialized, cardiac symptoms in children, care of patients, ivabradine on exercise capacity, 16-month, economic models, insufficiency, largest increases in incidence, hospital rankings, add-on diagnostic features, listing, icd-hf patients, budget, occluded stent, nbdmards, higher risk of 30-day death, criteria cardiac transplant survival, metoprolol, define hf, potential candidates for cell therapy, maladaptive cardiac, nephropathy, vco2 slope, animal models, higher risks, cardiovascular disease at baseline, subpulmonary, common language, home environment, unilateral renal dnx, contours, wall thickness, heart association class ii, readers, translational repression, cardiac events, dual energy x-ray absorptiometry, rhythm control therapy, moderate-strength evidence, paced groups, association between preoperative, improve management, il6, albumin levels, receiving pd, phosphorylation capacity, p38α mitogen-activated protein kinase, formalism, comprehensive echocardiography, contemporary use of devices, volume groups, cardiac-resynchronization, chronic pulmonary arterial hypertension, scenario, key genes, mitochondrial oxidative stress, increased calcineurin, key secondary outcomes, nonsignificant trend, descriptive assessment, risk of hf hospital admissions, core, comorbid, twenty-seven symptomatic adult fontan, prevention, reduced average length, wistar-kyoto, end-diastolic pressure, screening, hazard ratios for variables, fever, display cachexia, porcine model, status, world, fastest growing subclass, chromatin subproteomes, receive ongoing gdmt, bisphosphonate, fastest, failure trial, compared patients, odds, sst2 concentrations, exposure, myocardial washout, levitated lvas, catheterization findings, hybrid system, quality for hf, driveline, ratio, serial, intermacs, β2-adrenergic receptor, pulmonary embolism, untranslated, outcomes in exercise training, walk test, healthy volunteers, percentage of fibrosis, construct validity, early-onset hf, change in mlhf, beat-to-beat qt interval, case mix of hf, heartmate ii, peripheral muscle, nurses, saf cohort, af-free probability after catheter ablation, baseline covariates, increased body mass index, action on camp production, weekly, health system data partners, community outpatient settings, bridge to recovery, overlapping part, anthracycline-treated breast cancer patients, faster turnaround times, reliable diagnostic, mixed-methods, postoperative months, procedure-related, pronounced increases, hospital volume groups, shams, education, long-term clinical outcomes, brief review, time of inclusion, accessibility, overlapping, anemia in adults, upregulated transforming growth, end-systolic elastance, implantable cardioverter-defibrillator device, β-ar, acp, evidence-based medications, failure with preserved ejection fraction, limited success, linear pathway, association with dna, systolic human heart failure, roles, adhesion, randomised-controlled trials, assess social support, advanced chronic obstructive pulmonary disease, equitable access, 4-year survival rates, g-protein-coupled receptor, basal, included hospitals, uti, rate of death, designed clinical trials, rotor, forty-one, lower hf mortality risk in men, lower total expenditure, angiotensin receptor, sham levels by renal dnx, cost-minimization, high barriers, rad, case series, race by treatment interaction, outcome-monitoring, translocation, titin hypophosphorylation, percentiles, damage, guideline, greater in patients, apparent circulating nt-probnp concentration, failure clinic, hnorm, lists, 6-month period, including relax-ahf, continuous, guideline-heart failure registry, sham group, differentiation, composite measures of quality, prognostic factors, upregulated, cardiomyocyte-like cells, univariate, chronic heart, failing fontan circulation, month, surrogates, including lower risk, preferences, splice, s1pr1 downregulation, s12884 site, lv end-diastolic dimension, lv function, noncardiovascular diagnoses, onset af at risk, processes, evaluable plasma samples, second, new-onset severe, tolerance in heart, nf-κb, failure of xo inhibition, natural, tachycardic, splice variants, examined resistin levels, improvement in egfr, functional enrichment analysis, advanced heart, treatment for hf, myocardial loss of irs1, moderate reduction, diagnostic, adverse event rates, heart rate during exercise, ventricular action potentials, common form of heart failure, time-dependent analysis, atpase, electron, gastrointestinal, hf studies, terminal heart, sternotomy, expenditure on health, long-term mortality in patients, systolic blood pressure, habc battery, additional risk, acid, study participants, cardiopulmonary exercise variables, cardiac cachexia, life-sustaining treatment, include information, severe cad, candidates, observational cohort studies, 1-year survival in patients, group iii, expressions, abdominal, implications, adherence with exercise training, cardiac dysfunction during insulin resistance, lower mortality for hf, common form, median exercise-induced pasp increase, gender-matched, hdl-bound, readmissions, web-based simulation tool, heart failure rats, effort, serial measurements of cpcs, demonstrated diastolic dysfunction, calcineurin, diuretic resistant volume overload in heart failure, spectroscopy, cox proportional hazard, manner, intermuscular fat ratio, effects of fes, potential of mirnas, mitochondrial-targeted peptide ss31, nonischemic cardiomyopathies, nyha functional class ii, physiological significance, provision, qualitative study, left bundle, determine patient awareness, fontan circulation exhibit, downregulation influences cardiac hypertrophic response, β-blocker uptitration, gender-matched subjects, demand, early follow-up visits, normal hearts, activation of p38α, limited mitral valve opening, lower killip class, unchanged, linked administrative health data, novel intracellular antiadrenergic therapeutic strategy in hf, dystrophin-associated, l-dko, subsequent cardiotoxicity, cardiovascular morbidity, primary symptoms, inflammatory abdominal problems, isolated heartmate ii, situations, absolute increase in 30-day rehospitalization, nordic walking, tool, patterning, growing epidemic, successful reperfusion therapy, activation of vegf pathway, failure treatment, benefits of participation, mortality in women, coronary artery disease, congestive heart failure exacerbation, heart failure nurse practitioner, diastolic end diameter, aortic constriction, defibrillator implantation with cardiac resynchronization, recommended medications, arrhythmia-related, respect to alterations, sprague-dawley, expenditures, option, lung, failure index, costing, treatment strategies in patients, current status, remodeling aspects, biomarkers, administrative, replicating resource use, weakest for cardiologists, interventions in heart failure cost-effectiveness model, sinus, improved quality, association class, consistent across hospital volume groups, risks, olmsted, right, valve procedure, health care providers, medication dose, years after admission, randomized clinical trial, nursing-sensitive outcome, mechanism, advanced management, thirty-seven hospitals, community-based programmes on completion, 1-year mortality, patients with ras, follow-up exercise capacity, chf predictive model, negative coronary angiography, weeks of diet, bypass grafting, systolic heart failure, catabolic isoenzymes, vasculature, upr, elevations in bnp, compelling improvement after device implantation, degenerative mitral valve, altered expression, hhd, blocker, unilateral renal, demographic changes, tachycardia in response, leg, recorded mortality, decreased expression, experimental hf, failure cost-effectiveness model, majority of patients, lf, systolic heart failure treatment, young athletes, acute heart failure, increased hf hospitalization, hfref therapy, study-a, early risk of stroke, diuretics, identifying death, lv filling pressure, overview, immunoblotting, percutaneous coronary intervention, stroke prevention, reoperation, end points, neonatal, multiple-procedure drug-free success rates, management of myocarditis, transseptal, post-translational, intestinal, controversial, outcomes study short-form, pediatrics, nursing care, us, fm, untranslated region of messenger rna, survival of patients, canine electromechanics, alendronate, prognosis of c'd hf, il, ascertain frailty, mass spectrometry, descending, repeated interventions, activation, postoperative mortality in patients, blockers therapy, leukocytes, diagnosis of heart failure, greater in subjects, new jersey, et al, primary mechanism, magnetic resonance imaging on chelation, incidence, lusitropic, tunel assay, magnetic resonance postcontrast t1 time, medical literature, invasive hemodynamic, transcription factor gata4, cardiogenic, nuts, americans, prior myocardial infarction-both, antihyperglycemic drugs, sh, self-care of heart failure index version, acs consultations, substantial proportion of patients, measurable benefits, palliative, reduced long axis function, infusions, events at follow-up visits, use of bisoprolol, identifying cad, required isolated heartmate ii lvad, creatine, cox proportional hazard analyses, littermates, electrical stimulation, highest drs deciles, gene, cardiac plasma membrane levels of s1pr1, severe hyponatremia, cachexia, high-risk, ≥55, onset hfref, facilities, spite of developments, minimal, pulmonary arterial, majority of studies, patients into hf, increases alternative mrna splicing, secondary endpoints, impact of normalization, plasma n-terminal pro-b-type, hemodynamic phenotype, atrial pressure, baseline nt-probnp, remodelling, ad-c rats, twenty-seven studies, months of follow-up data, clinical deterioration, renal function in patients, extracorporeal membrane oxygenation, peripheral edema, notes, shape, catalytic, risk of gls, x-ray, role of pde2, ef≥50, clin, sound mind, within-day test-retest reliability, hf-induced remodeling aspects, intubation, prognostic biomarkers in patients, lower total expenditure on health, excellent, worldwide epidemic, temporal trends in hf, ventricular systolic, hdl function, mouse tac model, co-morbidity, circumstances, orthotopic heart transplantation, peak quadriceps force, ventricular assist system, opposing action, techniques, extent of benefit, transient receptor, intravenous iron, restoration, rates of hypertension, public, revascularization, treatment of heart, gdmt-treated nyha functional class iii hf, common in patients, structural, mineralocorticoid receptor antagonists in heart failure, extreme decile, hf rats, left bundle branch block pattern, 1-year period, transforming growth, total expenditures, hf symptoms, previous, efflux, right ventricle in heart failure, medical resource, women with hf, diastolic dysfunction, beat, preserve renal function, gls, cardiopulmonary exercise test investigations at study enrollment, anthracycline metabolism, promise, advanced heart failure patients, ability of bnp, team, rheumatic fever, rheumatoid arthritis, québec, laboratory characteristics, rvads, stimulation, acetylcholinesterase inhibitor pyridostigmine, ctnt, improve cardiac function, metabolic enzymes in patients, infarction heart, permanente, western blots, lower mortality in women, left ventricular dilatation, resonance imaging on chelation, transcription factor dhand, fifty-one percent of patients, anand, mitral annulus velocity, professionals, incorporating nursing-sensitive outcome measures, ser83 phosphorylation in hf, 12-lead, regulatory involvement, contemporary, large, derived composite quality measure, australian reference data, circulating fragments, central, pluripotency, difference in hf hospitalizations, cardiac specialty hospital, cardiology, common inpatient medical conditions, tnf antagonists, moderate, correlation coefficient, valvular, subtle, random-effects models, hdl-mediated, simple ecg parameters, exogenous, morpholino-based, doctors, heterogenous improvement in ejection fraction, open-label crossover study, binding protein-c phosphorylation, vehicle-treated, epitopes, method, body mass index ≥35, total expenditure, m, pathobiology, resynchronization therapy, progressive disease, preventive, measure, fewer cardiac procedures, refractory, independent hypotheses, electrical, protein response, systems level, venous thromboembolic events, increased energy expenditure, fat mass, standard error of measurement, diagnosis, bcl-2 proteins, fewer, guideline-recommended drugs for heart failure, apical rotation, mena overexpression in tta, adjustment for patient, intramuscular testosterone supplementation, sex-adjusted, rmsea, liver-specific irs1, chamber, 52-year-old man, patient with diagnosis, consistent with reports, shorter in patients, alternative treatments, outcome performance, high-volume ed cases, easily treatable, encounter children, subgroup, prediction of lv, included descriptive statistics, new york heart association classification, gtpase, comparable performance, β1-adrenergic, nucleotides contents, pulmonary resistance, von willebrand factor, large outcomes trial of heart failure, subunit, counterparts, economic analysis, rose, 30-day readmission, increase in 30-day rehospitalization, irs1, intramuscular, vivo inhibition, drs-stratified, nervous, free mass, cancer patients, concentric hypertrophy, typical adverse event, post-acute, precapillary ph with heart, heart circulatory failure, glomerular filtration, pathogenesis, attrition, duration of antiplatelet medication, childhood, precipitating factor, emotional status in heart failure patients, first-ever mi, low left ventricular, pathophysiologic state, stem cell, δ, additive, prognostic meaning, cachectic heart failure patients with respect, depression, factors of sh, higher eo-cfus, natriuretic peptides, mri, comprehensive, improved cardiac function, statistic, prognostic information, acs problems in patients, maximal exercise, ser83, underwent prospective assessment, ischemic mr with lv dilatation, first hf hospitalization, inflammatory, difficult problems, fibrosis, unfit men, cessation, resynthesis, association of hypoalbuminemia, exercise duration, cha₂ds₂vasc score, impact of implementation strategies, include proportion, initial results, anemia, bridging therapy, adenylyl, mechanical cardiac, end stage, michigan, inappropriate shock therapy, major role, underuse, improve hf risk prediction, min decrease, power spectral analysis, lower rates of hypokalemia, genetic susceptibility, exerts beneficial effects, lower risk-adjusted all-cause mortality, nyha classification, separate scale dimensions, automatic defibrillator implantation with cardiac resynchronization therapy, cost savings, lessons for nurse leaders, underwent heart, athletes, conditions in turkey, hf deaths, annular plane systolic, clcnka gg genotype, application, responsible diagnosis of heart failure, effect, reclassification, lack of improvement, pressure ≥, attenuation in lv dilatation, cardiovascular health, amount, iron, non-aa participants, curves, first diagnosis of af, autonomic nervous system, incident cardiovascular events, result, syndromes, debilitating stroke, btes, exercise training for heart failure, polytetrafluoroethylene tube, recipients, wide blood-flow paths, sulfonylureas, donor, chest, adamant, gradient, patients with type, cardiovascular diseases, impact of frailty, reverse remodeling after crt, erythropoiesis-stimulating agents in adults, previous pacemaker, determine prognostic significance, fistula, diabetic, pump-exchange, nomenclature, performed symptom, practical recommendations, healthy, economic analysis of patient management, improvements for patients, bradycardia, adjusted hazard ratios, insulin, contrast agent administration, validated measure, early transmitral flow, high incidence, reflect postsystolic function, first hospitalization, increased parasympathetic activity, acute decompensated hf, crt on versus crt off, influences patient outcomes, hogan, 2-fold, higher rates of hyperkalemia, improvement between baseline, independent, loss, kidney index score value, reclassification improvement, opposing actions, hazard models for time, myosin, peak oxygen, leaflet resection, physician continuity, incremental cost-effectiveness ratios from user inputs, adaptive response, favorable effects, mechanistic insight, properties, anti-inflammatory effects, contrast, outpatient, rv, physiology, patients with qrs, nonfatal, survival estimates, clinical modification, bioprosthetic, heart failure survey in israel, reduced parasympathetic control, screening patients, greatest difference, reciprocal, delayed rhythm control, ® system in heart failure patients, contents, myocardial titin hypophosphorylation, angiotensin-aldosterone, nitric oxide, median baseline, prognostic power, subspecialty groups, postmenopausal, failure admission, predictors of heart, american college of physicians, improves exercise, density, arbitrary, diseased human, capable, implants, combination with anticoagulants, altered regulation of rad q66p, attention control, combination, new understanding, primary end point, deaths attributable to heart failure, guiding exercise rehabilitation, myocardial infarction heart failure, multisystem, drive, consultations, sci, including quality, adult patients with heart disease, early detection, apoptosis, cv, studies, promote adoption, induction of scn5a variants, optimal cutoff level of nt-probnp, ≥10, assay, absolute value of mdc, heart disease, higher doses, pde, evaluation, circulating nt-probnp, clinical excellence registry from july, new-user cohort study, saxagliptin versus sitagliptin, riiα, identify chromatin-associated proteins, ad-flk rats, acute β-adrenoceptor blockade with esmolol, increase in peak oxygen uptake, tachycardia-induced, quality of life score, enrollment periods, national medicare data, ethnicity, patients with heart disease, detergent, participation, metabolic enzymes, longitudinal, deacetylases, grade, novel treatment strategies, elevated lv filling pressures, average age of patients, implementation strategies, published trials, infarction-related refractory, transmitral flow, implantable cardioverter defibrillator-crt in patients, rheumatic, clinical excellence, bp, compensated lv hypertrophy to hf, deleterious, substrate, demographic, disease-specific, advancement, mixed, driveline injury, potential predictors, implement exercise training therapy, hazards, alive, underwent device implantation, cardiovascular surgeons, curve, individual, angiotensin-converting enzyme, long-term follow-up, edwards lifesciences, gene-targeted, risk for heart failure, deaths, novel therapeutic approaches, centrifugal flow pump, s1pr1 agonist, blocks, insights, death, yorkshire swine, controlled trial, pathological stress, key role, dobutamine requirement, progressive loss, benefits of involvement, impaired cardiac metabolic gene expression, physician adherence to class, time-varying seattle heart failure model scores, highly heterogeneous, exercise rehabilitation, history of hypertension, hemodynamic disorder, receiving carvedilol, therapeutic implications, inappropriate, briggs, transduction, gly16, unilateral renal denervation, diseased cardiomyocytes, transplantation eligibility, early rhythm control therapy, prior cardiovascular disease, correlation with baseline hgb, improving functional capacity, trial-cardiac, permanent, assist device implantation, spontaneous cardiac dysfunction, exercise time, mandate, mdc95, alberta, extreme, absolute, spectrometric, complicity, beneficial effects of hrqol, renal artery stenosis, target patient population, artery stenosis, median stay, lipoprotein-associated, suboptimal, systematic search, audible, cardiac dysfunction, medical hospitalization in hf, cardiac angiogenesis in heart failure, congenital, increases in lung weight, euthanization, subvalvular, complications after implantation, treatment with carvedilol, dynamics, soluble concentrations, primary study end, multicenter automatic defibrillator implantation, lean body mass, bcl-2, plasma, neurohumoral, strength of race, patient-years, favorable changes, age-matched, management of heart failure, economic evaluations, jugular, trend, t1-mapping sequence, fatigue, end point, norepinephrine-induced hypertrophic responses, citrate, all-cause medical hospitalization in hf clinic outpatients, paradox, adherence, improve health outcomes, options, exclusion, medicare fee-for-service beneficiaries, modern rhythm control therapy, transcatheter approaches, requires diagnostic procedures, selective β-blocker metoprolol, quality-of-life score, renal optimization strategies evaluation, enrolled patients, physical, metabolic exercise, ventricular diastolic end, predictors of esrd, imaging on chelation choices, results, emergency department volume, effect on heart rate, tunel, antibodies, reach statistical significance, all-cause hospitalizations, rural, myocardial, uptake of class, cdp, novel therapeutic, reduced ejection fraction, antioxidant, treatment group, walked distance, vascular effects, beneficial effect, decreased mortality rates, population-based, web-system, oral glucocorticoid, reductions in lv, chronic myocardial, label-free, latin, severe-end-stage, explants, isolated pump replacement, harms of treatments, large trial, influx, higher dash diet scores, magnet, ie among study patients, haematopoietic cell transplantation, dedicated, developed incident hf, lesions, powerful prognostic composite hf index, progenitors, ca2, lcx model, isoprenaline infusion, small-molecule inhibitors, manipulation, weeks mi animals, stable chronic heart failure, regulates ventricular action, adjusted cox models, long-term outcomes, multivariate models, deciles, chf-inv group, system, future studies, elevated levels of epinephrine, mutant mice, underlying myocardial dd, unidirectional left-to-right interatrial shunting for treatment, undergoing vad, antagomir, zebrafish, cardiac chromatin identifies, training on outcomes, obese zsf1 rats, mouse, degenerative mitral, nested case-control study design, redesign, synchrony, pharmacological, intestinal morphology, saxagliptin versus insulin, full potential, maximum o2 consumption rate, enhanced hemocompatibility, intervention on adherence, low-strength, criteria, sdrr, north, phenylephrine-mediated hypertrophy of cardiomyocytes, humans, net-reclassification-improvement, modality, readmission, n-terminal probnp, clinical composite response, observation, situation, unplanned readmission, increased cardiac vegf expression, ratio ees, relevant, mitral, lower von willebrand factor, cascades, second evaluation, zealand, reader, score range, explant-derived, complex situations in pediatrics, breast, validated clinical tool, presence of diastolic dysfunction, protein, circulating, hypertensive, hand, caspase-3 gene expression, scarce, stenting, iii, purposes, limited ability, validation studies, sickle cell disease, set of transcription factors, shortcomings in research studies, ultrastructural changes, targeting nonterminal epitopes, ninety-three hf patients, foundation, requiring isolated lvad, conditional, york heart association class, independent predictors, evaluated functions, improving patient outcomes, truncated fragments, clinical outcome in patients, inflammatory markers, high morbidity, decrement of heart rate, pre-hct chest radiation, cha₂ds₂vasc, median, skeletal muscle sarcomere structure in patients, enhanced decongestion, northwest, early, cardiac sympathetic tone, β-adrenergic receptor activation, seventy-seven cases, shuttle walk, class ii, unique property, lv diastolic, malfunctioning heartmate ii lvads, patients at risk, t1-mapping values, canadian cardiovascular society guidelines, myocardial dd, preserved cardiac index, n-terminal, heart rate, depressed, perspective, rac2, pressure-overload, cultured cardiomyocytes, pathological remodelling, aberrant, confounders, proportional hazards models, microembolization-induced, regions, intensive transitions of care, received surgical palliation, pb, extent of cad, study-related, upstream, selective heart rate reduction with ivabradine, interquartile range, supplementation, hypertrophied, stable severe systolic, hospitalization for wrf, amyloidosis, impact of et, standard cardiac rehabilitation, osteomedullary, reduced gross income, β-ar responsiveness, upcoming, supports natural vasodilatory, cardiologist, potential, stress doppler, provide brief insight, glucose oxidation, cardiovascular event, single diagnostic test for hfpef, trichrome blue histologic analysis, impaired in fontan adults, lv end, consecutive patients with ph, off, multiparametric, adverse, predict heart failure, online material, drugs for hf, pb cycle, free wall, clarity, nonadherence, enormous clinical burden in adult medicine, risk of hospitalization, lower systolic blood pressure, myocyte hypertrophy antecedent to heart failure, voluntary, cox-proportional, new targets in disease management, interatrial shunting, institutional experience, human rad q66p, transplant ineligible patients, add-on, summary, inactive cxl-1051, henry et al, raloxifene-treated patients, wilcoxon matched-pairs signed-rank tests, pace dnx, thirds of patients, interconnected, rm, increased prevalence, 4-year survival, standard criteria, difference in heart rate, classify interventions, selective beta-blockers, risk predictor, children, oxygenation, diuretic therapy, kansas city, optimal treatment, mrnas, self-care management scale, maladaptive cardiac remodelling, clinical outcomes in chf, heart failure patient, 30-day readmission rate for patients, worse, atrial fibrillation for stroke prevention trial, care hospital, reduction, s, first, provide insight, homeostasis, pathophysiology of hf, female, reoperation for bleeding, tobacco use, differences, case, occurrence of heart failure, brachial, diagnosed patients, induced myocardial infarction, major, ability of gls, regulatory, include clinical outcomes, data sources, functional class, eov, basal heart rate, increased heart mass, recognition, echocardiographic predictors of response, exercise-induced pasp increase, regimen, severe systolic dysfunction, intensive transitions, ring annuloplasty, pyridostigmine prevents ventricular dysfunction, continuous wave doppler echocardiography, exercise-induced pasp, rrna, consultation to operation, past, ephesus, receive cardiac resynchronization, carries prognostic value, final data analysis, combine structure, researchers, cluster analysis, comparative, 30-day, neuro-hormonal system, extracorporeal life support, contribution of nursing care, perspectives, cardiomyopathic restriction, multiple-procedure, satisfaction, subclinical, activity, development of ie, surgical method, trial of heart failure, sham-dnx, symptoms of heart, iron deficiency, diastolic mitral leaflet motions, preserved lvef, sex-matched controls, pulseless, study selection, swedish web-system for enhancement, denervation, idealized lv, transmitral, catheter-based percutaneous revascularization, echocardiographic assessment, practice-level variation in use, great, placebo in addition, prolapse, renin, median bnp, hno, underlying heart disease, requirement, mitogen-activated, eplerenone in patients, performers, modifying antirheumatic drug, lean mass quantification, black, anxiety, second-generation, pulsatile afterload, statewide, interesting therapeutic concepts, determined pde2-mediated effects, doxorubicin-induced cardiotoxicity, fibrillation for stroke prevention, evaluated mice, artery bypass, biomarker approach, normal albumin, ingenuity pathway, vad support, development of ies, lvas, μmol, load-corrected chronotropic response, weeks of pacing, applications, positron emission tomography imaging, reduces total mortality, readmission among patients, greater antecedent weight loss, controls, entire, changes in nps, heart failure assessment of reduction, decline in ejection fraction, pilot, defibrillator implantation, swine, relationships, arm, non-linear measures, respiratory gas analysis at baseline, higher rate, venoarterial, defined prediction rule, rad variant, hypothermic, climate, modulate hf-related morbidity, pulse-wave, recommendation, prognosis of patients, patients with end, younger, receiving angiotensin-converting enzyme inhibitors, device consideration, fontan subjects, multicenter automatic defibrillator implantation with cardiac resynchronization, hepatic function, provide clinical recommendations, expertise, uv treatment, augmented cyclic guanosine, primary end, diseased, receiving optimal therapy, dystrophin-associated protein complex, cardiorespiratory, dxa results, wasting, lean body, agents, 1-year survival, proposed t1-mapping technique, percentage, persons, sonographic, severe lv systolic dysfunction, potent inhibition of l-type ca2, drug-untreated failing hearts, symptomatic improvement, consensus report, reduced sympathetic tone, hfpef population, differential impact on hospital performance, prognostic indicator, circulatory support, effective in hypertension, lv filling, global attenuation, omnibus, adverse outcomes, allowed prediction, sham levels by dnx, combined end point, diagnostic procedures, predict 4-year survival, heterochromatic chromatin, extracorporeal, exercise rehabilitation in patient, changes in sr, hold promise, community-based, diastolic failure, simple sex-specific model, short-term treatment with ivabradine, benefit of bb therapy, bottleneck stent, anova, stage heart, dash, reduction in lv, shift, cardiac nurse, ≥15, paradigm-hf, technique to exchange, severe frailty, manage af, multivariable logistic analysis, slows myofiber shortening velocity, left ventricular assist device, prolonged electromechanical delay, myocardial extracellular, mrna level for β-myosin, mitochondrial damage, mitral valve tethering, severe ai, periods, specific diagnostic, aric hf model, cardiopulmonary resuscitation, restorative effects, encouraging declines, support, median follow-up, base, end-diastolic dimension, sympathetic control of heart rate, acute heart failure in patients, calls, cardiologists, postoperative survival of patients, stratification, indeterminable anaerobic threshold in heart failure, functional enrichment, elevated resistin, elucidate, poorer vo2 max, anabolic imbalance, holosystolic, resource use, associate, transfusion, interpretation, adequate blood pressure control, future high, brain, n-terminal pro-brain natriuretic, specialty, continuity, acute right, death in crt-d recipients, rose acute heart failure, diastolic mitral annulus velocity, deficit index, iiib, transoesophageal, peripheral artery, exclusive, aggressive medical treatment for heart failure, qrs ≥160 ms, sympathetic, implantable defibrillators, optimization of diastolic, atrial tachyarrhythmias, atrium, regression analyses, interval from transplantation, logistic regression analysis, potential efficacy, p70s6, new users of saxagliptin, failure cost-effectiveness, use of immunoprecipitation, higher diastolic blood pressure, connecticut, heart dilatation, arg16, percentage of chf patients, propensity score, clinical care, end-stage renal, exerts, waist circumference, individuals, sodium, murphy, emd, converting enzyme inhibitors, including fat, age-dependent increase in incidence, negative inotropic effect, anti-inflammatory, non-frail participants, association between frailty, promising biomarkers, beck, ii infusion, signalling proteins, cardiac remodelling, hf epidemiology, life-threatening anemia, variant, unfolded protein response, ambulatory hf, discrepancy, covariates, severe hyperkalemia, patients with heart failure with preserved ejection fraction, nutrition in heart failure, ms, baseline serum creatinine level, activating myocardial pde2, improvements from baseline, preserved lv ejection fraction, isoprenaline, preliminary descriptive study, progenitor cells, preserved ef, withdrawal, heart failure questionnaire, peak aerobic capacity, chf-inv rabbits, trials of tnf antagonists, department, correlations among metrics, hm ii, risk for stroke, generate predicted outcomes, failing myocardium displays, co-primary, acute care hospital, acute care, halt disease progression, acetyl-lysine, total sample, practice rates of treatment, cardiac vagal tone, low left ventricular ejection, assignment, plasma samples, n-terminal pro-b-type natriuretic peptides in plasma, ethics rounds, 3-year event rates, diet group, treatment groups, diastole to end-systole, improves symptoms, size reduction by surgery, cardiopulmonary exercise test, flow-mediated dilatation, exercise tolerance, initial functional class, health-related quality, admission, paradigm shift, aortocaval, urgent readmission, weak recommendation, rank, vehicle, impact, c'd, higher in females, based definition, astronaut, left bundle branch block type, fundamental, chf-dnx, stress conditions, dacron patch closure, acs, immunohistochemistry, youngest group, form, agreement, ph, 6-month risk of death, robot-assisted training for heart failure, mediterranean diet score, collaboration of professionals, compliance with treatment, real-world setting, view, 28-day, acceptable internal, great number of studies, clinical findings, rates of patients, cardiovascular society, crt capability, fish, tricuspid annular plane systolic excursion, wk of pyridostigmine administration, predictive, borderline association, pre-defined, strong recommendation, south dakota, low-sodium dash diet, washout, massive, p-value for difference, dimensions, site-specific, projecting long-term costs, reduced mortality, β-adrenoceptor, scaffold proteins, embryonic gene programs in heart failure, reduced ventricular mass, development of rv dysfunction, gdmt-treated, magnetic resonance imaging, performed regression analyses, dyssynchronous hf, obstructive, published literature, mortality in childhood, branch, heart failure risk among patients, older adults with heart, cogeneration of nitrite, identical, chinese herbal medicine, rs10927887, sixteen, rv function on body composition, aggressive medical, rate of chf, overexpression, risk, unidirectional, competing priorities impact prescribing, low-risk group, tricuspid annular plane systolic, factor-κb, total adiponectin at baseline, bundle branch morphology, cost-effectiveness model, risk of heart failure, downward, placebo-treated group, serum levels, liver-specific, cv death, cf devices, reduction by ivabradine, class iii chronic heart failure, organisation, radiological, ischemia, cpg-recommended pharmacological treatment, twist, hf hospitalization, corporeal membrane oxygenation, thalassaemia, deficit, communication, community, myocardial function, limbs, highly effective, reduced lvef, bhlh, four-week aerobic training period, non-fatal, age-specific low, mortality rates, nursing management, bundle branch block electrical activation sequence, xo, pulse, mortality risk, morphology, hospitalized, cardiac catheterization, beta-adrenergic, ventricular systolic dysfunction, metabolic pathways, adjusted ankle-brachial index, medications, decrease mitochondrial respiration, coronary, normalization, cystatin, effects of air pollution, cardiac sympathetic, select patients, 57-year-old, promotes cardiac angiogenesis, service, avp through vasopressin receptor antagonist therapy, examined incidence, parameters, end-stage heart, poor outcome, tissuefaxs, heart failure research, bundle branch block, septal defects, abc hf, cumulative urine volume, survival to hospital discharge, insulin-signaling, diet scores with mortality, long-term prognosis, develop treatments, aerobic exercise training on peak oxygen consumption, increased ser83 phosphorylation, aortic, ischemic mitral, throughput, quartile, gene expression profiling, differential analysis, proteomic remodeling, development of chf, receptor potential cation channel m7, local myocyte depolarization, improves cardiac output, c-terminally truncated, efficient rv function evaluation, heart failure treatment, myocardial ischemia, challenge, policy, linear, ≥40, regression, improvement initiative, clinical outcome, saf versus pf, takes place, endothelial function in hfpef, mri scanner, psychometric profile, ies among crt-d recipients, reduction in mortality, tolvaptan, parasympathetic activity, follow-up medication lists, score with death, shunt implants, noninvasive surrogates for changes, obese zsf1 groups, health per capita, highly effective anti-neoplastic, higher in la, medicare patient safety monitoring system, remarkable, xo-mediated, working, lvad implantation, outcomes after discharge, assessed tm, reverse cardiac remodeling, at, trends, transcatheter aortic valve procedure, large cohort, muscle, case-fatality, neurohormones, trastuzumab use, increased, carcinoma, direct interaction, oedema, brief hypothermic circulatory arrest, catheter, medicaid 30-day readmission, blockade, weakest, isolated cardiomyocytes, criterion, cardiomyopathy in tuscany, background for aldosterone antagonist therapy, lv systolic indices, b-type natriuretic peptide, left ventricular diastolic end, und, rankin, ans mice, at-risk, cox regression analysis, multivariate cox proportional hazards regression, high bnp levels in patients, cardiovascular function, cm, micrornas in heart failure, content-driven telehealth, adjunctive, modified rankin score, experienced improvements, risk of potassium, autonomic nervous system activity on qtv, kidney injury, pathogenesis of heart failure, effect of caloric restriction, independent correlates of increase, isolated coronary artery bypass grafting, effective target, cardiac function in b-treated, left ventricular diastolic function, load-corrected, healthcare common procedure coding system codes, consecutive patients, output, proximal lad model, imaging on chelation, subunits, traditional, elastic n2bus segment, nitrogen, little, alternative, hrqol, randomized clinical, hazards models, hearts, estimation, cinahl in may, hypertensive heart disease by angiotensin ii infusion, acquired heart failure, treatments, acr, arrhythmia, s3991, thirty-day rehospitalization, clinical practice guidelines, italy, investigating hf-related cachexia, impact pay-for-performance, arbor, presence of mr, cardiac-resynchronization therapy in heart failure, pre-pd, early rhythm, pilot study, murmur, ras-blocker, dramatic, caspase, ventricular assist device implantation, eplerenone post, transplant-ineligible patients, entire cohort, pulmonary congestion, cardiac nurses, ethnic, average length of stay, international, spite, peripheral vascular disease, half of patients, protein levels, disease management, registry, exercise patients, transporter, animals, crude rr, human myocardial tissue, pure, unadjusted, high-risk subgroups, therapeutic implications of biomarkers, discharge among patients, ckd, analyses, sodium-restricted, part, upper, survival in patients, invasive hemodynamic assessments, gdmt, youngest, harms, physical exhaustion, multiple domains, lower peak vo2 at baseline, phenylephrine-mediated, patient care, sheet, reality, heart rate variability, mouse myocardium, indices, low co-morbidity burden, hypothetical programs, guideline-mandated usual care, single center retrospective observational study in children, study drug, neprilysin inhibitor, older age, cms metrics, higher readmission rates, effectiveness of implementation strategies, probability, ncdr pinnacle program, walking, questions, reduced risk, accepted peak oxygen consumption, meta-analyzed mortality, improve physician adherence, range 51-84 years, receiving guideline-recommended drugs, ml, meeting magnet, shunt implantation, therapeutic treatments, major hf remodeling aspects, air pollution on heart failure, cardiovascular outcomes in renal atherosclerotic lesions, antiarrhythmic medication, n-terminal pro-brain natriuretic peptide, consecutive case series, gadolinium-chelate contrast agent, medical staff, left-to-right interatrial, coronary artery, room, higher activities of paf-ah, t1 mapping, ≥50, survival rates, changes in treatment, propensity, percent, severe perturbations in components, μg, defects, panel, vena, region, wistar, warrants, normal, angiotensin-receptor neprilysin inhibitors, aric hf, assumption, onset, magnetic resonance angiography, diuretic effect, disposition, recommendations, psychosocial, new-user, african americans, clinical symptoms, biventricular support, trans, reliable in patients, prevalence of heart failure, university hospital, target audience, lvad surgery, hypoalbuminemia, pathological gene, myocytes, ne, measures, mrna, safe pump-exchange technique, β-blocker-induced enhancement, doxorubicin cardiotoxicity, signal transduction, early-activated septum, blocked phenylephrine-mediated hypertrophy, left-to-right, severe left ventricular dilatation, reasons for nontreatment, standardized, killip, treatment algorithms for de novo, mechanical, chordal, advanced phase, slower, t1 time, pf, left ventricle in heart failure patients, chf-inv animals, care transfer, walk distance, 2-vessel cad, allopurinol, reached primary outcome, patients with pad, habc battery score, cardiac performance by β-adrenoceptor blockade, cultured, total, myocardial collagen, recorded improvements, absorptiometry, β-blockers, interaction with lvef, nyha class iiib symptoms, evolution, traditional cost-effectiveness limits in models, reduced lv, first-in-man evidence, tests, patients with hfref, nmol, regression line, male, ans, multimarker-based strategy, automatic, non-dnx, assisted circulatory, alterations in body composition, yielded hazard ratios, complexities, western australia, left ventricular systolic, demonstration, patients without diabetes, mmol, united states, bet inhibition, remodeling aspects to emd prolongation, icds, length-force relationship, progenitor, determined changes, social mandate, higher psss, cuff, ischemic cardiomyopathy, xanthine oxidase, heart failure admissions, studies per outcome, incessant ventricular tachycardia storm, outcome measure, hf in patients, unloading, predictive cutoff value of nt-probnp testing, combined training, functional deficits, continuous-flow lvads, sex-matched reference values, mlhf, precede, distinct, management, signs, postmenopausal women with hf, induced recovery, outcome in heart failure patients, intima-media, questionnaire, broad, left-hand grip strength, obstructive pulmonary, btt, patient, obstructive pulmonary disease, enhancement of dapc protein levels, advanced copd, concerns, eventual resort, critical for adaptation, myofiber shortening onset, oscillatory ventilation, participatory, prospective hf registry, thromboembolic, mouse heart, failure patients, setting, centrimag rvad, decrease in length, increase in e, regurgitation, economic impact, phosphorylation, handling, outcomes in hf, transplant-ineligible, scaffolds, 8-fluo-camp, heart failure in children, moderate-severe right ventricular dysfunction, third, de novo, successful valve, vo2, oral glucocorticoid dosage, rhythm-control, acute kidney injury, practice site, unfavorable, heart failure hospitalization, muscle-wasting, tachypacing-induced, reperfusion, 2-vessel model, mutant, extracellular matrix, practice guideline, respective, nutritional, pathophysiologic mechanisms, new zealand white, prescriptive 4-year survival of patients, self-reported, randomized, linear models, proximal lcx, antagonist therapy, pulmonary arterial hypertension medication, low-volume ed, pattern, university of connecticut health center, 6-minute hall walk distance, inappropriate implantable cardioverter-defibrillator, slowness, acute right heart failure, careful management, assembly, dichotomized patients, higher bb doses, 63c→g, ≤75, older age group, first month, primary care clinicians, existing quality indicators, ankle-brachial index ≤, weight, vad, mrna levels for sr, obese, transmitral flow velocities, requires new prevention strategies, completion, increased peak vo2, meeting specific inclusion, point-of-care systems, results—retrospective, electrocardiographic q waves, ed, lower stimulation of phosphorylation, rvad, reversibility of heart failure, prognostic indicator in patients, glomerular filtration rate of 15-60, first-time diagnosis of heart failure, optimal therapy, lv dysfunction, effect of interventions, decades, tac-induced proteomic alterations, arterial elastance, lacking murine resistin, fractions, acquired cardiovascular risk factors, maximum oxygen consumption, hf model, single-cohort, nutritional abnormalities, selective, program infrastructure, lbbb, oct, integral, long-acting insulin products, bnp, early rhythm control, endothelial-protective, interactions, therapies, established cardiac disease, management of patients, tissue doppler imaging, dnx, improved ventricular-arterial coupling, provoke acute rv decompensation, cardiotoxicity, procedure, article, nonpace dnx, subjects with rv dysfunction, medical management of heart failure, case report, rat model, subtle changes on exercise, alleviate symptoms, remarkable role, variants, midregional, gene expressions of bax, pneumonia, incubation, failure with preserved ejection, american heart association, transcription factor, inflammation, svr index, early metabolic changes, magnetic resonance imaging on chelation choices, inferior, widespread, stop hypertension diet, simultaneous reduction, insulin resistance, age group, dietary recommendations, uk, elevation, drug, tuscany, extra, myocardial infarction, non-diabetic, body, occurring rad variant, co, moderate-intensity, quality of outcome measures, aor, odds ratios, young adults with heart failure, fluctuations, cardiovascular events after adjustment, change in serum cystatin c, intravenous metoprolol, groups of samples, health abc, health initiative participants, frequency, prevents, persistent af, maladaptive remodelling, serum resistin levels, follow-up visits as part, health behaviors, failure disease, lower rate, liberal transfusion protocols, ivabradine-treated patients, generation, inputs, impaired cardiac energy metabolism gene expression, fat-free mass index, search, receive cardiac resynchronization therapy, ischemic mitral regurgitation, strict, np measurement, single-cohort study designs, preceding mechanisms, renastur, low-volume, establish efficacy, improved efficiency, inclusion criteria, yorkshire, smallest, improved renal function, older counterparts, including heart failure, higher baseline sdqt-to-sdrr ratio, ecmo group, heart magnetic resonance, effect of exercise, renal underperfusion, flow-mediated dilatation diameter, mechanics, b-type natriuretic peptide levels in patients, ven, icu mortality, dcm, demonstrated favorable outcomes, confidence interval, hours of admission, bnp group, irvine, glu27 individuals, american heart, 2-year, exercise with testosterone group, jehovah, black ethnicity, affect outcomes, qt interval, ventricle, proximal, exercise training, nonischemic, mortality in adults, myocardial glycolysis rates, preoperative, highly relevant, surgical conditions, choline, reciprocal regulation in mouse hearts, new york heart association class, myocardial pde2, mitral annular velocity, antihypertensive medication use, treadmill, reliable, participant satisfaction responses, qt, pg, waist, mouse model, hct, treatment of mi animals, undergone coronary angiography, major adverse neurological, double-knockout, mechanisms, waves, confidence, new york heart, survey, classification of diseases, predictors of mortality, vegfr2, discontinuation of study medication, high-risk group, depression inventory, bypass, peripheral vascular, food, temporary, commissioning, 51-85, user, enrichment, antiplatelet agents, standard cardiac rehabilitation care, device-related, twice daily, york, predict prognosis, all-cause, independent of age, abnormal cardiac, acute kidney injury during spironolactone use, monomeric g proteins, vivo phosphorylation sites, lower risk, mitral valve opening, defibrillator-only, nyha functional class, nct00232180, left pulmonary artery, infarction, right atrial mass removal, hf readmissions in hfref, dt patients, blinded outcome assessment trial, baseline glomerular filtration rate, echo-derived, ic, first wk, ongoing gdmt, major changes, surgical ring implantation, assess national trends, baseline ecgs, good diagnostic performance, hours, sequence, double-blind trial, danish heart failure database, canada, effective treatment, heart failure population, role of bets, underwent aortic valve surgery, filling pressure, experienced electrocardiographers, difference-in-differences, dyssynchronous, study cohort, g proteins, uninephrectomy with ang ii infusion, primary endpoint, 57-year-old man, diastolic mitral, e'septal, wild-type littermates, feature, mild clinical diastolic dysfunction, mitral annulus velocities during systole, elevated mena expression, estimated glomerular filtration, within-day test-retest, hf in la, centrifugal, ventricular assist device, phosphocreatine to atp, prognostic factor in patients, domains, differentiation consistent with myofibre regeneration, expected future expansion, number, hf prediction, branch block, duration, emotional stress, pre-hct germline dna, risk reduction, short-term, decreased parasympathetic activity, clinician interviews, artificial, basic helix-loop-helix, diagnosed systolic heart failure, stretch, ldl-cholesterol, rgk, man, ability, ratios, codes, nonsignificant, get, caloric, general, doxorubicin efflux transporter abcc2, state of pka subunits, new options, acceptable alternative, management strategies, saxagliptin versus pioglitazone, rat ventricular, customized homogeneous sandwich alphalisa, human retn gene, lower btes, financial incentives, unclear, electric, increased level, gut, arteries, comparable across age, practice centres, renin-angiotensin system blocker, human hf tissues, log-rank testing, 6-minute walk test, follow-up tests, nondeveloped, uncommon, high clinical, lp-pla2, solid ehrlich carcinoma, pediatric heart failure, immunodetection of nt-probnp, precise role of mena, chronic hf-ref, uniform, circulation, hospitalizations, mouse hf, moderately effective, pharmaceuticals, chronic stable guideline-directed medical therapy, concordance, quality of care, post, identifies, outpatients, low-dose dopamine, aldosterone blockade, mechanical support devices, right ventricular contractile reserve, novel bottleneck stent, reduction in ea, non-hf, public health, 2-vessel, plasty, gill, interquartile, systemic hypertension, prognostic factor, device implantation, parallel with paf levels, non-sudden cardiac death, ambulatory patients with heart, discharge, females, chordal ruptures, remaining patients, cardioprotection, treatable pdrelated complications, common emergency department, controlled, abdominal aortic constriction, body composition, cytoscape, higher admission, myocyte diameter, ineligible patients, retn, outcomes in heart failure, component, sitagliptin versus sulfonylureas, identify risk factors, equation, role of nucleolin, detailed, hydrolysis, summary scores, cohort of patients, energy deficit, environment, anthracycline-related congestive heart failure in survivors, structured, beta receptor blockers, reductions in lvef, nonterminal, dyssynchronous heart failure, precapillary ph, chronic advanced, benefits of spironolactone, expression, composite end-point, users, cost-effectiveness of disease management programs, trends in hf, gem, pulmonary hypertension, human heart failure, specific antagomir, marked decreases in heart, anti-neoplastic, diastole, dodson, clinician expertise, prevalence, hospital, implanted monitoring devices, hand-searching relevant articles, larger fluctuations in beat-to-beat qt intervals, prescribed medications, inhibition, sarcomeric microstructure at baseline, assist device, changes in fm, inappropriate icd shocks, magnetic resonance postcontrast t1, termini, uptake, immunodetection, left ventricular assist, predicted death, cardiac, contemporaneous control group, quality improvement initiative, 66±3, real, collinearity, cardiopulmonary bypass, treatment plans for patients, impact of heart, implantation with cardiac resynchronization therapy, lyso-paf, preserved mitral valve opening, post-procedure, cocoa, stable phenotypes, hospital discharge in patients, testosterone, severe, direct comparison, 1c, city, doxorubicin-induced heart failure, first time, onset of symptoms, 25mg, effective rate, structured exercise programme for patients, sham-inv, interventions in heart failure, pacing, serum potassium level, capillary wedge pressure, aa participants, feeding, qtv, integrate data, baseline echocardiography before crt, rhythm control, norepinephrine, numbers, conditions, ontario, including cardiac hypertrophy, adiponectin, perk activation, mg, experienced, population of anthracycline, end stage kidney failure, disease risk score, extensive functional characterization, fluid overload, disease groups, cis, medicaid services demonstration, patients with diabetes, apex, nervous system, quality-adjusted, diminished expression, number of cases, cardiomyopathy origin, mediterranean diet, risk in communities, alcohol, pay-for-performance, recreational, guanylate, standing blood pressure, investigations, nursing-sensitive, face decisions, aging, cells, hydrolytic, riα, demonstrated excellent risk stratification, effect on ie risk, eccentric, ras-blocker uptitration, higher-than-expected rates, exerts positive inotropic, β-adrenergic receptor agonist, cox model, weeks with repeat metabolic, lipoprotein, surgeons, patient safety, inhibiting tgf-β receptor type, multiple disciplines, peak quadriceps, maisel, time-domain, treated hypertension, involves changes, icc values, volume overload, markers of hemostasis, fatal arrhythmia events, organisation of care taxonomy, murine myocardium to heart failure, rr, particles, line, nonselective β-blocker, main outcomes, cerebrovascular, changes, branches, pulmonary hypertension patients, management interventions in heart failure cost-effectiveness model, body mass index levels, telephone, reduction in hospital length, raas, balance, change in thigh muscle, renin-angiotensin-aldosteron, class iii to class ii, sympathetic control, costs across volume groups, younger patients, mechanism of cardioprotection, nt-pro, years of age, real-world, definitions, heart failure after cabg, gse9128, contextual reasons, cardiac death, pressures, control animals, patient management interventions, video edge detection, ph with heart, mitral annular, reversible with metoprolol, defibrillator-crt, demonstrated compelling improvement, comparison, murine equivalent, triggers desensitization, global changes, economic analysis of patient, adaptation, crt on versus crt, successful mitral valve, cardiac injury, patient circulation, bisphophonates, aggressive protocols, n-terminal fragment, multiacquisition, specific signalling pathways, ≈30, surface, lean, diuretic efficacy, pro-b-type, adults with anemia, triangular, patients with hf, cost-effectiveness of heart failure disease management programs, content-driven telehealth system with care management, desensitization, bisoprolol, humanized male mice, patients with end stage heart failure, pulsatile devices, literature, risk of event, morphogenetic, cinahl, protective effects, divergent etiology, statistical improvement, low-volume physicians, pre-specified subgroup analyses, transitions, hypothesis-generating findings, decreased stroke volume, explant, incremental shuttle walk test, prevalence of hf, neprilysin, body of evidence, reduced cardiac fibrosis, pulmonary arterial vasculature, relevant health service provision, cardioverter defibrillators, incidence of pump dysfunction, advanced chronic, level, dual ras, hospitalization rates, intolerance, develop chf, mitral annulus, decisions, older patients with breast cancer, pro-brain, cardiac autonomic balance, high-strength, guideline-recommended treatment for outpatients, quality-of-life, weeks after aac, new york heart association, permanent periodic breathing, periprocedural, placebo-treated, hypertensive heart failure, variable, biology, protection of mitochondrial, proteomics changes, usual care group, including death, glucose, ambulatory heart, mouse rad, platelet-activating factor, renal disease, principles, ed visit, sandwich, randomised, model-predicted survival, end of life, skeletal muscle mass, sequential, spontaneous vt, replacement, arrhythmia-related costs, european society of cardiology guidelines, bundle-branch, consequences, race influences, ka, cardiac volume overload, tunel-positive cells, exercise intolerance, operations, membrane, leaflet opening, hospitalized hf, disease management programs in heart, reductions in lv end, months, ion, centers, adequate, serum factors, european society of cardiology, fat loss, velocities, mortality, positive, sarcomeric microstructure, cardiology-cardiovascular, surgery consensus report, seattle, hf admissions, resources, massive embolism, food-frequency questionnaires, seconds, left-to-right interatrial shunting, complication, primary efficacy outcome, shortness, ste analysis of twist, cardiac biology, new therapeutic, bromodomain, molecular biomarkers, congenital heart lesions, selection, target, pressure volume relation, overall summary, exercise training in hf, thrombotic obstruction, weekly trastuzumab administration, saxagliptin, reducing length, ≤30, independent risk factor, thromboembolic events in patients, evaluations, model, years, mena, hypoxia, increasing population, competitive collateral growth patterns, lower mitral e, reasons per patient, women, spironolactone use, cardiomyopathic, high bnp group, observational cohort, prediction rule, failure survey in israel, factor, electrolytes, heart rate variability in risk stratification, pd, noncardiologist physicians, failing hearts, progression of heart failure, proportion of patients, correction for age, sham, q65p, size reduction, ventricular diastolic end diameter, array, infarct, metoprolol in heart failure, vt, low, retrospective chart review, ischemic cerebrovascular events, single-payer, incubation of ec, lower costs, hypothetical, cardiac arrest, repression, sixteen new york heart association class, average weight loss, receptors, risk for heart, band, lvad patients, study-drug, disease-specific costs, adults with ejection fraction ≤, contextual, vagal, cardioverter-defibrillators, chronic β-adrenergic receptor stimulation, echo-doppler, higher functional capacity, aerobic capacity, physiological proteolysis between pro2-leu3, electronic databases, 1a, recruitment, stable coronary artery disease, thirteen patients, prognostic, improve myocardial perfusion, mlhf questionnaire, snp, eplerenone post myocardial infarction heart failure efficacy, post-tac, noncardiovascular, neoangiogenesis, levels of nps, arthritis, implantable cardioverter-defibrillators, influence adherence, portion, anaerobic threshold, midpapillary, receiving extracorporeal membrane oxygenation membrane support, differential effects, challenges, valid, anthracycline-induced cardiotoxicity, cardiac event, low-dose bb, von, arguments, ramirez-sanchez, multivariate, history of hf, hyperkalemia, self-care maintenance scale, outcomes of care, procedures, injections in patients, xo-mediated ros, right heart circulation, noninvasive, dual x-ray absorptiometry, chromatin-mediated signal transduction to pol ii, healthcare utilization effects, rad q66p, cardiac patients, risk of hyperkalemia, eligible, promising biomarker, higher expenditures, blacks, woman, lean zsf1, improve symptoms, norepinephrine requirement, implantable cardiac, medicare inpatient data, pump thrombosis, ventricular longitudinal, hyperinsulinemia, prodrug, dialysis-dependent, adjunctive treatment for patients, sdqt-to-sdrr, receptor antagonists, achieve guideline-recommended target doses, ventilatory, financial costs, primary safety end point, ischemic etiology, nt-probnp levels, ventricular-arterial coupling, subsequent events, cf, index hf hospitalization, restorative, carotid baroreflex, enrolled participants, hazard ratio, interagency registry, presence of signs, np, differences in presentation, postoperative echocardiography, lower socioeconomic status versus whites, score-matched, autologous, tolerance, lacking nucleolin, kinases, standards, paucity of data, western australian, improve outcomes, major complications, hospitalisation, key, pressure ulcers, cardiovascular events as subjects, bnp level, patients as control, good evidence, advances, defence, data among groups, distinctive, current ongoing cardiovascular outcomes in renal atherosclerotic lesions, site, refractory cardiogenic shock, ventricular, vegf, grip, general populations, diastolic function, pacing-induced, gait, scenarios, included home telemonitoring, self-care confidence, regular physical activity controls, risk of heart, epidemiology, developed acute kidney injury, composition, infarction-related, sitagliptin, process redesign contextual framework, local, responsible, expressed genes, efficacy of spironolactone, cardiac function, follow-up visits, normal albumin levels, normal cardiac, practitioners, adenosine, sites, postexercise, simulation, β2-adrenergic, promoting transcriptional pause release, effective off-pump sternal, s'lateral, prior, aged, crf distribution, ras, edge-to-edge anastomosis, predicts clinical outcome, modes, maladaptive, difficult, congenital lesions, rtq-pcr, european, predict inhospital mortality, left ventricular ejection time, dyssynchronous failing heart, documented prognostic factors, degree of ms, large trials, chain, advancement of science, hereditary, lower limbs, inotrope-dependent, risk factors, x-ray absorptiometry, collaboration, provide patients, success, extend, subcellular alterations by metoprolol, measurable, risk-adjusted, new strategies, tomography, mini-sentinel, lvad, contemporaneous, collateral, ingenuity pathway analysis, dilated lv, extent, subunit rac2, bax, microscopy, priorities, multivariable-adjusted, large phase, test for interaction, compute odds ratios, multivariable hierarchical regression models, english-language trials of blood transfusions, western, porcine, adjustment, ii, central to hf pathogenesis, potential therapeutic implications, pharmaceuticals in patients, pol, tac surgery, camp-dependent, lower, crucial role, esrd, multicenter studies, masked outcome assessments, date of death, decreased rrna transcription, small, quality of life assessment, altered ventricular structure, renin-angiotensin-aldosterone system inhibitors in heart failure, efficient, fontan circulation, follow-up period, acute coronary syndromes, shortcomings, pooled placebo group, lv end-diastolic dimension index, insight into mechanisms, well-being, cs during vvd, pathological hypertrophy, hospital discharge, transcatheter, mrna splice, inflammatory stimuli, coronary artery bypass grafting, lc-ms, log rank, therapeutic left-to-right interatrial shunting in patients, care, low left, beneficial effect on mortality, considerable national attention, min without bolus, outcome in patients, adenoviral, l-type ca2, basis, resistant, dialysis-dependent patients with heart failure, tertiary, composite primary outcome, risk of mortality, hospitalization, underwent triangular resection, guideline-recommended medications to adults, extended, left ventricular mechanics, historical, maladaptive molecular processes, metabolic abnormalities, resort, coprimary end points, cardiac index, identify implementation strategies, holosystolic murmur, glycolysis, initiated therapy, ventricular diastolic function, novel approach, reaching statitistical significance, coronary heart, framingham heart, developmental, aggressive medical treatment for hf, intraclass, lv mass, function of baseline sst2 status, treatable, accurate recognition, expression of pluripotency markers, subclinical atherosclerosis, mitral e, diet adherence, effective for patients, topics, corporeal, mortality in patients, cyclase, collaborative, developments, mena overexpression, strategies, microarray, hospitalized patients, decade, altered, rs synchrony, diuretic use in heart failure, aged ≥18 years, event-free rate, key health, european hf guidelines, degree, heart rate response, regulator of growth, sample, hf-ref, diet score components, aspects of remodeling, worst, qrs prolongation, march, program of exercise, lvet, effects, diameter, cox proportional hazards models, adding ctnt, college of cardiology, combining parameters, crude 28-day case-fatality rate for patients, sst2 measurement, ≥18, nondeveloped countries, rgk protein, muscular strength, physician volume within strata, conscious, eras, multiparametric echocardiographic, bolus, fully magnetically levitated centrifugal-flow chronic, included ambulatory icd patients, rm strategies, ventricular cardiomyocytes, questionnaires, strokes, frailty, all-cause mortality, mitral flow, economic considerations, involved single parameters, gluconeogenesis, nurse, surveys, novel, common disorder, gene expression profile gse9128, echocardiographic substudy, apparent, determining individualized assessment, myocyte differentiation, concept, reverses remodeling, creatinine, crt on, mass, age of participants, helpful, health status in patients, effect of exercise training, coagulability, technique, mild mitral regurgitation, therapeutic functions, embryonic gene, major branches, 10-year increase, reversible myocardial ischemia, β-blocker dose, cumulative dose, index ami, implantation, erythropoiesis-stimulating, pathways, cs during avd, time to esrd, baroreflex activation therapy, ambulatory heart failure trial, postoperative normalization, rehabilitation in patients, uptitrations, detect hf, underwent heartmate ii lvad, improving muscle function, β-blocker dose changes, unintentional, univariable, objective, patient compliance, renin-angiotensin, within-day, competing risk, value of mdc, heart function clinic at university health network, involve perturbed bone, sinus rhythm, chronic advanced heart failure, randomized control, depressed myofibrillar, unilateral, volunteers, university of connecticut heart failure center, therapeutic options, 3-year mortality rates, ethnic groups, amyloidotic, reflective, distinctive components, atherosclerosis risk in communities study, mid, median age, cardiac stress, point of care, surrogate, incident hf cases, leaflet motion, guidelines-heart, mitochondrial dysfunction, spectrometry, primary outcomes, reproducible, dakota, sized, lactate, fitness, hospitalization for hf, implanted monitoring, produced cardiac dysfunction, perceived lack, heart failure, symptoms, nonsurvivors, demographics, characterization, ad-c, prescribe exercise rehabilitation, troponin, genuine effect, β-blocker dose increase, l-type channel isoforms, 90-day, tricuspid valve, cardiac dysfunction with conduction abnormalities, insurance, guidelines-heart failure, conferred increased increase rate, diagnosis of heart, continuous flow, heart failure with preserved, pred, novel finding, comment, total myosin, field, university of michigan hf, hyperlipidaemia, history, angiotensin ii, wk of treatment, β1-adrenergic receptor, addition of habc battery scores, error, inhibitory, signaling pathway changes, hearts of ans mice, time-dependent covariates, 6-minute walk, littermate, hospitalisations for heart failure, reserve, pump exchanges, hypotheses, exercise intolerance in heart failure, terminal heart failure, chinese herbal, university of michigan hf clinic, mrna splice variants, lv reverse, low pasp, clinic notes, aric, treatment, exercise training on outcomes, beta-blockers, ef ≤30, chronic kidney disease epidemiology collaboration, primary study end point, chromatin-associated, consenting ambulatory hf patients, criteria cardiac transplant recipients, randomized aldactone evaluation, vco2, third trial, fontan, medical treatment for heart, infarction heart failure, heart-specific, preoperative clinical characteristics, 7-day, crt-d, infarcted hearts, guideline-recommended, renin-angiotensin system, surgical tactics, heartmate, preserved, median egfr, untreated, frequency of administration, challenging, global longitudinal, non-lbbb, angiotensin-converting enzyme inhibitor, hf under drug treatment, therapeutics, abnormal body composition, cohort study, characteristic curve, nonfatal outcomes, heart failure in rats, heart failure with preserved ejection, cross-sectional, human resistin in heart failure, national efforts, swedish, dose-dependent reduction, days, malondialdehyde, restriction, relationship between pathobiology, hypertensive lv dysfunction, abnormal liver texture changes, base of treatment, denmark, source, reconstructed, ventricular ejection fraction, biosynthetic enzymes, background, worsening renal function, hospital quality improvement initiative, odds ratio, levitated, spironolactone in adults, male patients with chf, noncardiac, tricuspid, japan, pka, video, wild-type, platelet-activating, b, higher transfusion, mirnas, receive bisoprolol, subunit expression, practice, programme, main outcome measures, adult population, percent of hospitals, concrete, approach, analysis of patient, partial improvement, magnetic resonance, hemodynamically unstable, medicare hospital claims, role for inflammation, clear organic, exertional, mediator, affect reclassification, 6-week follow-up period in patients, statitistical, antagonism, programmed cell death, medications among outpatients, 57±22, reactivation, amplitude, research design, early-onset, air, trastuzumab users, remove heart iron, protocols, long-acting, blunts beta-adrenergic responses in cardiomyocytes, dyssynchronous nonfailing, men, bet family bromodomain proteins, improvement of cardiac, patients in heart failure, mixed-methods study, reduced sympathetic control, unit costs, rose acute, indications, surgical treatment of post-lvad ai, hospital readmission reduction program, echocardiography at baseline, muscle strip, undiagnosed heart disease, precipitating, patients with chf-nyha-iii, help patients, solid, exercise, benefit patients, medical treatment guidelines, value, left atrial, hscrp, receives little attention, signal, body weight, hypokalemia, pde2-overexpressing cardiomyocytes, quantification, nyha functional assessment, controlling heart rate, high-density, ratios for pcwp estimation, spearman, produced reverse remodeling, annular size reduction, 10-cell, small-molecule, seattle heart failure, resting hemodynamics, final evaluation, catecholamine, black race, precise, gene programs, expenditure, congestive heart failure visits, predictive value, rv function, maintain sinus rhythm, canadian special access programme, cdp choline, animal model, understanding, central blood pressure, historical data, congestive hf, deactivation discussions, model fit, anthracycline-containing, recommended target dose, smallest difference, resynchronization-defibrillation for ambulatory heart failure trial, right ventricular end-diastolic area index, peritoneal, outcomes of exercise, disease complex, transplant process, increased hf, infrastructure, propensity score decile, patient with heart, severe developmental impairment, lean mass, lower total, catabolism, grading of recommendations assessment, renal denervation, heart block, arginine, subproteomes, promising biomarker in heart failure, higher baseline crf, epifluorescence microscopy, x12, ratings, implantable cardioverter, criteria cardiac transplantation, trichrome, shorter 6-minute walk distance, high-frequency, shunt, involving ventricular assist devices, unfolded, g-protein, current assays, cohort, malignancies, β-adrenergic, limited evidence, external, moderate reductions in lvef, cumulative, higher mortality, communities, extent of rv dysfunction, placebo-controlled, rs13058338, atherosclerosis risk, standard error of measurement value, included listing criteria, benefit, reversible by metoprolol, 20-week, relative risk among trials, older patients, limited number of patients, link between air pollution, left atrial area, new-onset post-lvad ai, concurrent hf, beagle, age groups, myofiber dynamics, tricuspid annular plane, vascular endothelial growth factor protein, patient categorization, icd shocks, post-myocardial infarction patients with heart failure, exercise variables, selected practices, trpm7, af in patients, addressing practice-level differences, consecutive patients with pad, inverse association with mediterranean diet scores, frequent, control, large idiopathic, groups with heart failure, homogeneous, symptom, contrasting groups validity, hospital mortality, index, kilogram, severe reductions in lvef, spontaneous ventricular tachycardia, herein, debilitating chronic disease, angiotensin, sources, nfat, impact of rv function, myocardial extracellular matrix, ultrasonography, supporting iron use, zung, catabolic, greatest, left ventricular assist device implantation, total symptom, utility, long-term ventricular, reductions, scientific, web, prospective validation cohort, exposed group, sd, size, suboptimal care of patients, st2 level, systolic, pressure-volume conductance catheter system, organic lesion, valuable, upstream signal, vasopressin type, tm, comparative effects, figure, age-specific, favorable, detecting normal filling pressures, serum sodium levels, colleagues, highest, preserve atrial structure, overexpress scn5a variants, separate sub-sample, reversible, thirty-day all-cause readmissions, implantable cardioverter-defibrillator deactivation preferences, proportional, active individuals, national trends, experienced centers, systolic blood, ontario case costing initiative, adoption of heart failure guidelines, correcting nutrition, cardiac gene, fibrosis of heart failure, bioenergetics, group, elucidate mechanisms, dithiothreitol, peak respiratory quotient, diagnosis of hfpef, study objectives, improved short-term, classic, national patient safety initiatives, remote monitoring, advanced hf, scales, vascular diseases, rule, longer mutually exclusive, increased sympathetic tone, prostate, levitated centrifugal-flow chronic lvas, stimulation of cgmp synthesis, medical hospitalization in hf clinic outpatients, evidence-based treatment, referrals, nonidentification, out-patient, median bnp in women, selecting controls, volumes, murine, electrocardiographers, diet scores, danish, 25th-75th percentiles, ≥35, effect of if-channel inhibition, adults with hf, quantitative proteomics, sts, high-dose bb, function, religious, low-volume hospitals, energy metabolism, gender-matched control subjects, absolute risk of heart failure, reliability, evidence on associations, secondary end points reflective of decongestion, free-breathing pulse sequence, suspected hfpef, group ii, placebo, at1, long-term administration of pyridostigmine, hno donor, ventricular cardiomyocytes in response, functional status, inclusion, includes age, models, receptor antagonist, g, s1pr1, preoperative albumin, atherosclerosis, august, underwent testing, self-care education at discharge, reduces afterload, myeloma, english language on anemia, distribution in hfref, coronary microembolization-induced hf, human hf, transplant with mt, prevent sudden death, all-cause medical hospitalization, disease progression, cellular plasticity in cardiomyocytes, planning, elevated activation of p70s6, november, hf pathophysiology, life, china, embolectomy, intermediate frail, international right heart foundation working group, suggesting myocardial angiogenesis, arbitrary start date, type, rwt, bottleneck shape, underlying pathophysiology of heart failure, saf, molecular pathways, inhospital, atrial myxoma, acute β-ar stimulation, cardiovascular, first month after discharge, postoperatively secondary, number of hf risk factors, local cardiology services, interview, binding, combined contributions, decile, out-patient follow-up, risk prediction, negative cross talk between cgmp, mitochondrial-targeted peptide drugs, diameters, dl, novel noninvasive tools, attendance, site specific riiα, higher heart rate, oxide, circulatory, regulator, cardiovascular events, nucleotides, proximal circumflex artery, clinical effects, chf-nyha-ii, contributions, isolated, good diagnostic, all-cause hospitalization in heart failure clinic outpatients, evidence-based treatments, haematopoietic cell, baseline egfr group ii, preoperative demographics, texas cancer, zsf1 groups, cd133, angiotensin receptor antagonist valsartan, minutes, residual, improves functional status, unstable, q, study patients, discharged patients, failing fontan, current measurements, contractile efficiency, participating nurses, outcomes in african americans, up-regulated, innovation, expression profile, low-strength evidence, cardiopulmonary exercise testing, adjuvant setting, subsequent heart failure, adverse consequences, signs of heart failure, steady, operative, methylatropine, symptomatic systolic heart failure, right atrial area, required biventricular support, hospital admissions, trend toward enrollment, chronic systolic heart failure, doxorubicin-induced heart, hfref, pathophysiology of hfpef, ambulatory patients, shunts, atrial fibrillation for stroke, enhance decongestion, pathology, relative decrease, nyha class iii, management programs, ii-iii, heart failure in pigs, embase, skinfold thickness, growth, trastuzumb-related chf, ref, made policy recommendations, delay, bridge, associations, hfpef animal models, diet, aldosterone, β2-adrenergic receptor haplotype, renastur cohort, cross-talk, plans, comparison of outcomes, stable clinical conditions, end stage heart, continuous-flow, undergoing procedures, radial arterial tonometry, median rate ratio, ligation, extracellular flux analyzer, relationship between physician volume, cardiovascular complications, poorer, valve, profile, inverse, atrioventricular, scores, undergo reverse remodeling, heterogeneous, samples, interaction by ef, pulmonary, 79·1, cardiovascular risk, home, entry, high, efficacy of carotid baroreflex activation therapy, multisite study extend, fibrillation, hypophosphorylation, peak early diastolic, provided better-than-usual support, traditional myocardial, peak o2, high-volume physicians, mitochondrial oxidation of glucose, common problem, specific, inhibit cardiac l-type channel activity, fractional flow reserve measurements, interaction with exercise training, valsartan, resource, origin, angeli, mitochondrial oxidative phosphorylation, cava, iron homeostasis, modern acute heart failure, testosterone therapy during exercise rehabilitation, pluripotent stem cell-derived cardiomyocytes, lancet, inferior vena cava, trial of exercise training, augment cardiac output, reduce mortality, remarkable increase in camp hydrolysis, catheter ablation, differences between patients, myxoma, prescriptive, statistical parameters, quality of life, exhibited worse outcomes, scaffold, classes, hf risk, discrimination, atrial fibrillation for stroke prevention, access, trastuzumab-related chf, implantable cardiac arrhythmia devices, longitudinal analysis, all-cause mortality for sts hh, use of spironolactone, systemic adverse events evaluation, excellent hf prediction model, angiotensin-receptor blocker, careful clinical evaluation, pluripotency marker, commoner among women, heart failure myocardial tissue, functional electrical, cox, ami patient, underlying clinical trials, probnp, negative, congestion-like, decreases in ejection fraction, long-term cost-effectiveness analyses of disease management programs, increased attention, heart failure cost-effectiveness, reference subjects, ventricular support, therapeutic strategy, nationwide retrospective cohort study from denmark, reasons, atropine infusion, relevant to individuals, ea, clinical deterioration of hfpef, prognostic assessment, new-onset aortic insufficiency, mis, south, preserved left ventricular, retention trial, follow-up, flow velocity, pre-hct exposure to anthracyclines, egfr group iv, end-point, heart failure disease management, contemporary trends in heart failure, file, goal, evaluable, patient consultation, targets, cardiac sympathetic activity, impact of rm, low-quality evidence, repeat, cardiac risk, delayed enhancement imaging, hospitalized heart, proangiogenic effects, guidance, kccq, qualitative, hand2, kaiser, ventricular assist, thigh, fpassive, objectives, erc, raloxifene-treated, hh, therapy with ivabradine, age-dependent effect, heart failure mortality in men, therapeutic targets, principal mechanisms, prescribed, anoop shah, time of admission, distinct circulatory derangement, control therapy, medicare, small pilot study, circulating progenitor, armamentarium, study, degradation, indicative for surgery, outcomes in patients, 6-week follow-up, experience, diuretic refractory severe-end-stage hf, downregulation, integrated discrimination, antiarrhythmic drugs, infarcted left ventricle, pathway analysis, pathological changes in cardiomyocytes, fewer admissions for individuals, pilot trial of heart failure, repeat ed visits, lower in fit, populations, anti-oxidant defence, laboratory variables, irs2 gene double-knockout, large-scale clinical trial, induce heart failure, leaders, ss31, daily clinical practice, reduced mortality risk, outpatients with heart, abundance, cardiac filling, diameter stenosis, legal, sympathetic tone, troponin t, higher-than-expected, rest, transcriptional, induced heart, common contextual reasons, neurohormonal, stimuli, thoratec corp, disciplines, biventricular, diabetes status, progression, pollution, severe hf, log, logistic regression, taub, collagen density, alter chromatin structure, management interventions in heart failure, hypertensive heart, long, intensive transitions of care program, bioprosthetic aortic valve replacement, propensity-score, mediterranean, testosterone levels, kaiser permanente northern california, thirty-day, imbalance, management programs in heart, receptor blockers, adenine nucleotides contents, converting enzyme inhibitor, witness, co-morbidities, respiration, guideline-mandated, preoperative serum, demonstrating development, vivo assessment, non-diabetic patients, cellular dysfunction via irs1, points, studies in hf, advanced chronic organ failure, rat left ventricular, guideline recommendations in heart failure, office hours, recommended target, assess np levels, posterior wall, mitral filling flow, patient management interventions in heart failure cost-effectiveness, thrombosis, postsystolic, continuity equation, reviewers, residents of olmsted county, dedicated hf units, ad-flk, effect on pb characteristics, post-translational state, sex-specific models, inhibitor ivabradine trial, american heart association guidelines on evaluation, nonterminal epitopes, involving families, dose, demonstrated restricted closure, lifesaving drugs, treatment of chf, fully magnetically levitated, exercise-induced increase, bromodomain inhibition, improve prognosis, aberrant reactivation, endothelial-protective effects via stimulation, poor prognosis after lvad surgery, donors, primary, influences outcomes, self-care management, benefits in exercise capacity, reduction by surgery, emphasis-hf study subgroups, vasodilatory, explored sex differences, hypertensive hfpef, attempt, higher hospitalization rates, therapeutic alternative, chart, inferior hospitals, esrd in outpatients, treatment for heart failure, in-hospital, multivariate regression, generate estimates, physicians, crt in patients, hr, providing prognostic information, correlations, beta1-adrenergic, cardiomyocytes, gas, included diabetes, randomized clinical trials, one-year event-free rates, hand2-dependent, exercise group, haplotype, include cognitive function, distinct populations of patients, chloride, ≥60, high-risk patient with heart failure, tumor, eseptal, physical therapy, proportional hazard, dietary patterns with outcomes, strongest, induced heart disease, abcd, ischemic heart failure, powerful, resolution, advisors, treatment of hfref, extracorporeal membrane, kinase activity, preliminary report, cell, interest, plateau, gill index, preliminary study, treatment of patients, heart failure scans, evidence-based management, turbulence, clinical response, absolute change, secondary to multiorgan failure, allopurinol rats, findings from heart, initiatives, trainings, ef, variability, good long-term value, minnesota quality of life, developing heart failure, intensive care unit, class iii, improvement in contractile function, ill-defined, underwent heart transplant, middle-aged recreational athletes, blood pressure, eligibility status, integrated discrimination improvement, gating movement, patients with dyspnea, circulating forms, strong, basis of heart failure treatment eras, pre-post comparisons, short, weak, proof-of-principle cohort study, higher than ecct, ecct patients, frame, catecholamine infusions in rats, care programme, angiotensin receptor neprilysin, american, high-fat diet, descending coronary artery occlusion, dual inhibition of at1 receptors, gene expression profile, gastrointestinal regions, exercise parameters for diagnosis, developed, cascade, baseline electrocardiogram, high-risk patients, patients in sinus rhythm, circulating progenitor cells, accumulation of deficits, body mass index, icc, propensity score-matched analyses, high-quality work, higher risk for hf, new york heart association class iii, cpcs, content-driven telehealth technology, gene expression omnibus, urinary, dialysis-dependent patients with hf, failure disease management programs, increase, incidence of hyperkalemia, lower exercise performance, s'septal, trastuzumb-related, july to december, older with type, renal impairment, autopsy, heart failure at rest, series, remodeling, converting enzyme, medication changes at follow-up visits, neurotransmission, peripheral arterial disease, event rates, ivabradine, unique, myocardial insulin resistance, 6-month event, original, selective β-blocker, action, ed volume, prediction, large study sample, hf in infancy, apex during baseline, decreased mortality, cardiac resynchronization, heart association class iii, processed forms, full medicare coverage, extrapolating short-term outcomes, nonpublic, role in cc, current economic climate, p38α, operationalized hospital quality, chemotherapy-induced heart failure, tidal respiration for quantification, misdiagnosis of heart failure, camp, collins, nosignificant changes in control group, mix, pressure gradient, aggressive medical treatment, dietary approaches, collagen cross-linking, low performers, end-stage congestive heart failure, normal lv ejection fraction, gene program, non-dilated left ventricle, angiotensin receptors blockers, transfusions in patients, confidence level, efficacy outcome, incident systolic heart failure, adults with heart failure, effects of carvedilol, osprey, reduced cardiac diameters, choice of chelation regimens, cell adhesion genes, atrial natriuretic peptide, endothelial function, ie, filtration, mitochondrial oxidative, postmarketing, acute coronary, time frame, clcnka polymorphism, ecgs, nct00180271, dialysis-dependent patients, anterior, responsive, full, 1-year mortality rate, portal hypertension, underwent hct, aortic blood flow, single, study-drug discontinuation, severe hypertension, ranked hospitals, glucocorticoids, fat-free, precedes hf, all-cause readmissions, ventricular contractile reserve in patients, final diagnosis, lvet between admission, cerebral, include prospective studies, flow-mediated, dopamine, experimental models, individualized, online, burden of heart failure hospitalizations, respective molecular pathways in patients, diastolic mitral flow velocity, futility, care for patients, non-invasively, increasing btes, reduced quality, right atrial pressure, impaired systolic function, declines in length, symptomatic on exertion, human resistin, bmi, cellular responses to heart failure, including calcium-sensitizing agents, heart failure in latin america, leg strength, reference lists, observational study, variability measures, january, ventricular dysfunction, pro-brain natriuretic peptide, larger studies, absorption function in patients, effective arterial, additive adverse impact, severe heart, increased exercise capacity, vasopeptidase inhibitors, uncertain, acute myocardial infarction, increasing body, new targets, cases, self-care, content, canadian data point, tissues, beneficial effect of exercise training, metric choice, heart failure nurse, improving uptake, m7, linked administrative databases, end-diastolic, filtration rate, soluble guanylate cyclase, l, conventional surgery, elevation in resistin, effective, insertion, β-blocker uptitrations in patients, risk model, blood testing, barriers, sites in north america, knockdown, hemostasis, blood transfusions, systolic excursion, restoring functional capacity, aldosterone antagonism in heart failure, small gtpase rac1 activity, littermate controls, improved discrimination, upr effectors, regulate expression, consecutive consenting, erythropoiesis-stimulating agent, incessant, rm interventions, decongestion end point, fit men, general hospital, categories, prolonged emd, life for people, moderate lv dilatation, afterload burden, lv ejection, represents true change, benefit of af ablation, non-cachectic, hf hospital admissions, antagonist, adenovirus, madit-crt study, david, undergoing isolated heart transplant, busy, older, artery, cgmp, time-limited, lack of hypertension, collagen, routine measurement, mortality in hfpef, strain rate, weeks, interplay, left ventricular dyssynchrony, adverse cardiovascular, index score, including mortality, oxygen consumption, rehospitalization for stroke, sampling frame, intermediate, α-myosin, nordic, improve short-term mortality rates, arterial systolic, physician follow-up, pro-brain natriuretic, hemoglobin, ≥70, functions, simpler laboratory report model, clcnka, stronger, cardiovascular event rate, skeletal muscle abnormalities, domain, peak oxygen uptake, ventricular end-diastolic pressure, exercise score, identification, hospital length of stay, sequence-specific, 4-fold induction of serum resistin levels, decreases, research, study end, cardiovascular death, erythropoiesis-stimulating agents in patients, direct renin inhibitors, metric, chromatin-associated proteins, conservation, confidence in estimates, mitral valve area, effect of lvef, identifies patients, capillary, mild heart failure, predictor, developed hf, binomial, medical outcomes study, days of hospital discharge, features of heart failure, gating, second-generation sulfonylureas, diagnostic performance, place, evidence-based, ejection fraction ≤, fig 1c, low-volume eds, data in patients, predictive cutoff value for admission nt-probnp, high-dose, modest reduction in mva, implantable cardioverter defibrillator-crt, lower mortality, failure hospitalization, anthracyclines, number of hf risk, institute, adoption, advanced heart failure, health care expenditures of patients, healthy cardiomyocytes, proportion, defibrillators, review, lowest, iii–iv, angiotensin receptor blockers, egfr, cardiac resynchronization therapy, foster collaborative research initiatives, hearts of tta, changes in energy metabolism precede, well-treated cohort, cardiovascular hospitalization, single-arm analysis, robot-assisted gait therapy, long time, cardiac murmurs, pressure-overload-induced hypertrophy, repair, potential dysfunction, year, comparing b-treated, s1pr1 cardiac gene therapy, pure hno, hipsc-cms, genomic scale, qt intervals, prognostic indicator in heart failure, self-care confidence scale, patient enrollment, risk of chf, hazard ratio for death, heart failure clinic, subscales, intubations, subpulmonary ventricle, obvious, common forms, doppler, czech, prevalent, cardiac explant, paediatric, outcomes, aldactone evaluation study, major clinical trials, families, rotation, hemodynamic features, office-based, antiadrenergic, median follow, stem cell source, new york heart association class ii to iv hf, off-pump, forty-one patients, 6-week fes program, cognitive impairment with 6-month mortality, new therapeutic approach, ankle-brachial, failure registry, centre, endothelial repair, spectral, mellitus, mammalian, hf in rats, first-time, g-protein-coupled receptors, centers for medicare, specific aetiologies, onset heart, diastolic indices, consecutive case, estimates, inducible myocardial ischemia, crude rates, worsened prognosis, experiments, multiple myeloma, improves cardiomyocyte bioenergetics, tendency, open, liberal, neurohumoral blockers, aortic valve procedure, new antiarrhythmic drugs, molecular scaffolds in heart pathology, classic signaling paradigms, protective mechanisms, abolished protein expression, inhibitory actions of rad, highly dynamic, end-tidal, frequently abnormal, wide qrs complex, radiological signs of hf, cox-proportional hazard models, intermediate odds ratios, wt, bioprosthetic valve replacement, data processing, left anterior descending, decline, detailed transcriptional analysis, requiring surgical intervention, competitive, affairs hf clinic, sickle, multivariate cox regression analyses, circulating plasma ne, chronic insulin exposure, widespread use, preserved lv, degenerative, prescription, beneficial effects, tissue doppler, vads, ser77, β-blockers therapy, rales, use of erc, practice-level variation in rates, worsening, analysis, heart failure-related hospitalization, essential role, fractal, quadriceps force, gain attention, q65p substitution, degenerative mitral regurgitation, repeated echocardiography, youngest patients with hf, sst2, shock therapy, cellular, regulation, gross, outcomes among patients, cardiac mena deletion, sham-operated animals, anticoagulation, revision, types, number of hospital days, successful, previous studies, rapid onset, unfavourable, systematic, esmolol, guideline-heart, pad, vivo experiments of hf, month after discharge, heart failure adherence, myofiber, newer imaging techniques, kidney index score, late-activated, bivp, albumin levels during lvad, resonance imaging on chelation choices, major concerns, elevated levels, medical therapies, unsuitable, pause, relation of hemoglobin, medical outcomes study short-form, protein-c, temporal incidence, myocardial diastolic dysfunction, life-threatening, placebo-controlled clinical trial, gait therapy, retrospective cohort, chf-derived, confirmatory, molecular dysfunction, major databases, angiotensin-converting enzyme inhibitors, perioperative, diverse community-based cohort with incident, duke activity status index, 2-fold increased risk, pna, exhibited striking differences, ii heart, central pattern generator, deactivation, new pharmacologic targets, peripheral muscle pump, decrease in score, sex, readmission rate for patients, myocardial tissue, aortic valve insufficiency, variability in qt intervals, male sex, doxorubicin treatment, sst2 values, discrimination improvement, transgenic mice, eight-week-old, discharge patients, year of oht, included body mass index, prescribing angiotensin, fetal gene program, myofilament, increased lv compliance, hypertrophy to heart failure, produce test results, commoner, cardiac support, provided venoarterial dilation, macrophages, estimated, gene expression, university of connecticut, good results, characteristic, transplant, cooper center longitudinal study, predictive cutoff value, cardiomyocyte-like, proportional hazards, included previous revascularization, fewer depressive symptoms, isoproterenol, detection, cronbach, multihospital, expression of bax, good model, prevalent hf, nodularity, topic, post-acute care transfer, baseline hgb, arrhythmia substrate after ami, occurrence, antitachycardia, battery score, previous spironolactone use, cardiac development, 7-day follow-up, adult male wistar rats, cardiovascular mortality, rates of ed visits, examined transfusions, clinic, progression of heart, requiring pump replacement, channelopathies, soluble, aggressive dose uptitration, antiplatelet drugs, ventricle in heart, adverse neurological, heart failure disease, implantable cardioverter-defibrillator shocks at end, risk for esrd, myocardial fibrosis, sts hh, marked protection, disease, ec coupling gain, feasible, higher frequency of diabetes mellitus, anthracycline-induced, camp hydrolytic activity, equivalent, severe mr, systemic vascular, markers of skm growth, failure, defibrillator implantation with cardiac resynchronization therapy, conductance, coronary intervention, improves prognostic resolution, relationships with mortality, hospitalization in hf clinic outpatients, percutaneous, test, resonance imaging, normal samples, left ventricular, composite of death, duke, ventricular contractile, financial, uncontrolled, high-density lipoprotein, quantitative, parametrized diastolic filling formalism, primary composite endpoint, epigenetic changes, cxl-1051, parameter, ss, operative outcomes, physician, lv dilatation, diabetic zsf1 rats after heart failure, ph with heart failure, adjustment for covariates, tac-induced, program, decrease mortality, kcl-ki, idealized, paediatric cardiac transplants in children, chf than nontrastuzumab users, decompensated hf, reduced atp content, exercise-induced, protocol-driven, ivc, lability, choices, stable heart failure, progression from hypertrophy, structure, cycle, channels, health insurance, male gender, patients with chf, renal function in children, characteristics of hf, association between treatment variation, proteins, electromechanical delay, attention-controlled, block, perturbed mitochondrial function, index version, low bnp group, crucial target, glomerular filtration rate, decompensation, changing doses, theory, design, circulating mediator, preserved ejection, including cancer, impact of carvedilol, young adult jehovah, chop, composite measure, eligible patients, progression of hf, circulatory assist device, targeting specific effector molecules, major public, independent association between spironolactone use, autonomic, allocate specialized hf resources, increased peak, better-than-usual, left ventricular assist devices, long-term mortality as patients, pinnacle, pathological cardiac gene expression programme, lung congestion, main outcome, edge-to-edge, multisystem disease, treated survivors, inhibit l-type, dna, evidence based, α-myosin heavy chain, qol, medical therapy, cardiac pathology, myocardial pde2 expression, sixty-one, determination of risk, etiology, compare, detrimental, impaired lv relaxation, extracellular, diagnostic testing, baseline, treatment implications, global proteomics changes, temporary right ventricular support, consequence of heart rate variation, endothelin, clear, dpp-4, infusion, transfer, increased atp demand, outcomes in hf patients, composite end point of esrd, change in peak vo2, post-aac, enrollment period, antitachycardia pacing, function in patients, additive effect, t1-mapping, exhibited features, β1ar, bisphosphonates, air pollution, misdiagnosis, angiotensin receptor neprilysin inhibitor, association between race, atrial explant-derived, polymorphism, vascular, congestive heart failure, concomitant, improved, interleukin receptor family member, peripheral artery disease, moderate-quality evidence, acute hospital facilities, raise awareness, joanna briggs institute evidence based practice, time domain heart rate variability, blue, north america, risk for hospitalized heart, little influence, pubmed, final achieved bb dose, human heart, atheromatous, week, socioeconomic, canine, web-based, mva, integrated dynamic resistance training, stiffness, intensity, neurohormone, pulmonary arterial hypertension, mini-sentinel program, leaflet configurations, ventricular contractile reserve, authors, consistent benefits, translational, underwent redo sternotomy, concentrations, velocity, mr with lv, physician follow-up after discharge, chinese, high-cost medicare beneficiaries, hf patient plasma by use, filling flow volume, potential benefits, prognostic purposes, differential, sphingosine-1-phosphate receptor, radiological signs, major predictor, mitochondrial-targeted, destination, prospective data, use of antagonists, drs-stratified hazard ratios, resonance postcontrast t1 time, complementary model system, chemotherapy, kaplan-meier curves for death, change in cystatin, lack of correlation, hospital anxiety, avd, cardiac rehabilitation care, echocardiographic evaluations, lv end-systolic volume, true, sympathovagal, outpatient settings, guidelines, serum cystatin c, student, included 6-minute, skinfold, hf hospital, comorbid conditions, c level, readmissions as part, group until day, modification, combination of exercise, renin-angiotensin-aldosterone system, nontraumatic death during sport, diabetes, first-in-class angiotensin receptor neprilysin inhibitor in heart failure, patients with hfpef, timed, mitochondrial-targeted peptides, modulates ea, ninety-three, unique post-translational states, adolescence, financial burden, multicenter automatic defibrillator, conclusions—low-volume, paf-acetylhydrolase, prior hf, random-effects, apoptotic signaling pathway, humanized mouse model, cardiac insulin-resistance, third heart sound, resistance, exercise training on kccq, indication, beneficial impact, neprilysin blocks, nested, restored β-ar responsiveness, receiving ventricular assist device support, control group patients, reason, level of application, recommend blood transfusions, transplant recipients, scn5a electric remodeling in hf, latin america, constriction, expansion, all-cause death, trials, annular size reduction by surgery, modes of l-type channel inhibition, increased functional capacity, consumed erc, ameliorates mitochondrial dysfunction, plateau phase, self-management, ventricular assist devices, low-dose nesiritide, primary efficacy, limitation, improved outcomes among patients, change in distribution, post-myocardial, creatine kinase, consistency, nonmitochondrial, current cardiology, severe end-stage hf, ethically complex, exercise-induced pulmonary artery systolic pressure, transcription factors, rise, reduces morbidity, hdl-mediated vascular effects, prognosis in heart failure, ≥160 ms, camp-dependent protein kinase, large animal model, auscultation, low skeletal muscle mass, concomitant treatment with ss31, therapy, right atrial, regression models, bcl2, incident hf, promising, low left ventricular ejection fraction, angiotensin-receptor blockers, rv failure management in pah, value in hf risk prediction, hrqol from exercise training, doppler mitral inflow velocity, times, paf-cpt, grip strength, vo, anecdotal, sex-matched, patients with systolic, functional, cardiovascular reason, mortality as patients, sudden death, hazard ratios, importance, therapy in patients, iv hf, internal reliability, people, sustained improvement, madit-crt, treatment heart failure, southeastern minnesota, hf after mi, lv ejection fraction, functional abnormalities, epithelial, poor patient compliance, aerobic exercise training, heart failure in patients, channel mrna, channel inhibition, degs, small studies, refractory congestive heart failure, clinical practice guideline, predictive cutoff, young adult, pressure-overload-induced, benefits of anemia treatment, lvad support, beneficiaries, continuous relationship, effect on hdl function, peptide levels, secondary outcome, marked, second hf, end of diastole, predictive cutoff value for plasma, heart failure trial, success rate, left ventricle, coupling, ejection, defined set, lean body mass ratio, generally higher, increased right grip strength, danish registry on dialysis, two-center, cluster, re-hospitalization, cytoskeleton, severity of heart failure, risk avoidance, subject, animal, health-care, published taxonomy, seattle heart, ventricular longitudinal systolic, showing minor improvement, unintentional weight loss, primary efficacy end points, briefing, survival projections, included patients, lyso-paf acetyltransferase, testimonies, total cholesterol, va cohort, hfpsi, candesartan in heart failure assessment, elderly, kidney disease, chromatin structure, average follow-up, prognosis in hfpef, tonometric indices, proportional to lv dilatation, community hf cohort, additional prognostic benefit, plasma b-type natriuretic peptide, robust predictor, non-biological disease, confirmed hfpef, inpatient use, follow-up measurement, cytoskeletal, randomization, health problem, implanted cardioverter-defibrillator device, reconstructed aortic pressure curve, promising targets, conclusions—low-volume eds, rankings, improvements, date, ≥60 ml, precapillary ph with heart failure, angii, lung weight, cri, adequacy, left ventricular ejection fraction, channel α-subunit, anthracycline-related, preventable, eighty-one, health buddy program, reduce costs, relationship between sex, patient factors, ten-year experience, generating variants, right-sided cardiac catheterization, permeability, cardioprotective signaling, diastolic, early physician follow-up after discharge, hospitalizations for patients, real world, increased mortality, remaining indices, lv, min, age-dependent, qrs morphology, first results of studies, 10-week treatment period, crt on assignment, kaplan-meier analyses, obesity, guideline-directed, preoperative renal, atrial pacing, receptor, broader discussions about end-of-life treatment preferences, covariate, increased contractility, link between inflammation, heterogeneity, borderline, aas with hf, exercise with testosterone, estimates of resource use, left ventricular ejection fraction ≥40, hemoglobin levels, new conditions, immunoreactive nt-probnp, one-year, pathological, affect electrolytes, readmissions in heart failure, undergo coronary angiography, higher metabolic exercise, lokomat, referent age group, pathophysiologic mechanism, aortocaval fistula, dyn, all-cause mortality in patients, cardiac explant-derived cells, activation therapy, lv remodeling, apoptotic, delayed, indicator, in-trial, clinical composite, fashion, extending emd, association of cognitive, state, early measurement, groups of rats, terminal stage of chf, quality-of-life scores, behaviors, lv reverse remodeling, exercise hemodynamic status, terms of medication, outcomes of nursing care, muscular, northwest united states, vagal tone, thirds, settings, ≥65, determinants, arterial, lack of achievement, organic, readmission metric choice, veterans, mice, congestive heart failure in humans, sudden cardiac death in athletes, cpg recommendations in hf, inventory, doxorubicin, iv heart failure, protective peptides, candesartan in heart failure assessment of reduction in mortality, baroreflex, fes, sex-specific model, physio, messenger, annular plane systolic excursion, beta-blocker dose, cardiac magnetic resonance postcontrast, unfolded protein, diminished akt→forkhead box class, nesiritide strategy, proanp, atrial fibrillation in patients, study period, conscious hf rats, cumulative urine, demonstrates initial safety, quartiles, biomedical, signal transduction cascade, management interventions in heart failure cost-effectiveness, mg daily equivalent dose of metoprolol succinate, self-care of heart failure index, etiologic, mild mr, post-transplant, reference, exclude cad, displays, egfr group, infarct size, accessory, provide potential benefit, functional electrical stimulation, resynchronization-defibrillation for ambulatory heart failure, completely normal, coding, beagle dogs, public health problem, role in hf, common consensus, survival rates of patients, role in hf care, western blot, hand grip, heavy chain, phospholamban, sham levels, measurement, conscious dogs, sham-operated, intrinsic left ventricular dysfunction, mitral valve, net economic savings, psychosocial factors, human-to-human, neutral results, adults, acetylcholinesterase inhibition, reality of heart failure, comments, markers for coagulability, effective way, proportional hazard models, hm, abcd classification, polytetrafluoroethylene, practices, eccentric hypertrophy, end-systolic, β-blockade, pronounced symptoms, difference, development of heart failure, occlusion time, plane systolic, defibrillator, older adults with heart failure, naviaux, requirements, medical hospitalization, requires careful evaluation, cardiac magnetic resonance imaging, minnesota, mm for reference subjects, improve clinical symptoms, scanner, left main, hallmark of type, mitochondrial proteome changes, echocardiographic predictors, exercise programmes, narrow qrs, crucial problem, 4-fold, potential of diuretics, acceptable, sts hm, pyridostigmine, pah, involves failure, annual, underwent catheterization, kansas, suggesting postcontrast, advantage, improved mitochondrial structure, adjusted hazard ratio, bottleneck, mi, inhospital mortality, antihyperglycemic agents, wild type, ten-year, divergent, emean, primary outcome of death, insulin-resistance, high-cost medicare, older athletes, gata4, david tools, class iii–iv, lower median activities, copd, key regulator of cytoskeletal actin dynamics, well-recognised, prior stroke score, group iv, mouse ventricular, explains variance, descriptive, heterogenous, constants, aortic valve procedures, crt in dialysis, 3-month, mild disease, leaflet repair, differential relations between cpcs, moderate anemia, hospital volume, decreased cardiac irs1, nursing to outcomes, cardiac benign tumors, internal consistency, lower hf, reduced skeletal muscle mass, experience in japan, low apparent, opening, clear organic lesion, albumin levels during lvad support, groups patients, variables, term, risk for hospitalized, threefold increase, organizations, relative wall, responses, higher amount of malondialdehyde, transfer-based, survival study in heart failure, post-pd, require consultation, pulmonary capillary, reduced, frailty in heart failure, surgical indication, ii fontan, trastuzumab, mr, diastolic tethering, deficiency, genomic, test-retest, overstimulation, over-represented, ventricular assist device use, methodology, adenine nucleotides, combined, post-myocardial infarction heart, decrease, transplantation eligibility status, conducting studies, national cardiovascular disease registry practice innovation, chronic renal failure, periprocedural deaths, modern, retrospective descriptive research design, right ventricular-pulmonary arterial coupling, joint, phenylephrine-induced genes, mandatory, analyze bivp, nanog, nontrastuzumab, deposition, systolic hf, food-frequency, hf progression, older persons, adaptive, evaluated st2 levels, clinical studies, increases, intermediate outcomes, time-varying, hospital quality, association of cognitive impairment, improves lv contractile function, treatments for anemia, ischaemia, egfr group ii, la, biomarker for hfpef, little impact, event-free, 55-85, subjects with ra, beneficial new therapeutic approach to chf, right heart, tnf antagonist, dogs, pre-specified, equipotent dosages of carvedilol, score of minnesota quality, downstream, medication, europe, speckle, inflammation-stimulated resistin levels, cardiomyopathy questionnaire, ri, beneficial effect of arni, free wall cs during vvd variation, decrease in re-hospitalization, bleeding, conclusion, improved functional capacity, opposing responses, impact of physician continuity, vector, negative predictive value, compensatory, allocation ratio, cardiovascular event-free rate, hnorm group, untreated acf groups, looping, magnetic, failure patient, calif, exertion, time of heartmate ii implantation, worsening of heart, increased sarcomere shortening, nonfunctional, contention, distinct g-protein-coupled receptors, guideline-recommended target, antagonists, breast cancer, β-adrenoceptor blockade, exacerbates heart failure, high-sensitivity, cardiac hypertrophy, s1pr1s, peak, icd-hf, separate, post-transplant mortality, ≥160, training-induced changes in hrqol, interconnected molecular pathways, early medical management of hf, radiation, training-induced, complex, newer drugs, sympathovagal balance, homozygous, reduced wall, risk of hospital, fat, outcome ratings from admission, reducing ea, fixed-rate, audience, protein kinase r-like er kinase, production by ec, pevk segment, days of acs consultation, acf ± allopurinol, rate for patients, cardiac magnetic resonance, protein kinase, cardiac myocyte-specific mena overexpression, enrolled, maintenance of sinus rhythm, invasive haemodynamic assessment, hospital clustering, erasers, moderate heart failure, nursing, ischemic samples, 0-7 days after mi, transfer-based assays, hospital compare, akt, wilcoxon, pulmonary capillary wedge, adjusted odds ratio, healthstar, california, bat results, contemporary heart failure, incidence of hf, muscles, recurrent, salt, symptoms of heart failure, middle-aged, classify patients, challenging therapeutics, s3991 site, ±, survey in israel, predictive validity, secondary end point, fewer days, all-cause hospitalisations for tm interventions, rigorous, inflow, reverse remodeling, secondary outcome of death, major cardiovascular complications, seer-medicare, course, bone, rate-control, poc measurement of nps, life expectancy, surgical intervention, standard practice, single-centre, myocyte, right ventricle, removal, multivariate analyses, atherosclerosis risk in communities, records of surface ecgs, telehealth, electronic, coronary angiography, framework, initiative, unfit, af type, grafting, beta-blocker hypo-response, taxonomy, echo-doppler cardiography, correlates, reduction with ivabradine, mitochondrial oxidative phosphorylation capacity, reversal, biventricular pacing, health status, signaling pathways, exacerbation, vegf pathway, expression of target genes, erythropoiesis-stimulating agent therapy, calreticulin, molecular mechanism, framingham heart study criteria, inpatient, cardiorespiratory fitness, patients with baseline, mr-proanp, effectiveness of bisoprolol, standard echocardiographic measurements, biventricular dysfunction, postoperative, actin, erythropoiesis-stimulating agents, context, area, susceptibility, relations, cognitive impairment at hospitalization, gadolinium-chelate, left ventricular assist system, assist devices, therapeutic interventions, selected citations, relationship, liver, tapse-to-pasp, trials-enriching patient identification, large-scale prospective randomized multicenter trial paradigm-hf, elastic, inhibition of protein kinase, adjunctive treatment, genotype, end-diastolic volume, treatment of end stage heart failure, kg body, heart failure in mice, lvet at entry, absence of changes, pre-crt lv, endpoint, grading, including nuclear factor, fully reversible, library, disorder, systemic vascular resistance, pulmonary arterial systolic, jugular venous pressure, basic relevance, hazard models, trial, downward regression line shift in nonsurvivors, higher phosphorylation, dialysis, annular velocity, survivors, 52-year-old, common, general anaesthesia, improvement in peak work rate, profound change in paco2, depression scale score, oxidative phosphorylation, altered protein kinase, mm for psoriasis, treatment aims, superior, longitudinal rv fiber shortening, heart failure nurses, subgroups, attributable, plane, reduction in risk, good agreement, september, recommended therapies registry, b-type np, cholinephosphotransferase, diastolic murmurs, stable hf, inroads, hdl, venous pressure, p, hf mortality in fit, acs consultation, hand grip strength, approaches, ineligible, western blot analysis, low-risk, use of loop diuretics, heterogeneous region with hf risk factors, velocity time, time of discharge, fundamental hypothesis, end stage heart failure, heart failure patients from italy, biopsy, thirty-day mortality, heart team, province, levels of mena, diagnostic approaches, comparison of predictors, patients with new york heart, monitoring devices, implementation of medicare, knowledge, tonometry, onset of hf, biomarker-guided clinical trial design, exercise performance, receptor haplotype, acute dyspnea, quality of care programme, scientific literature, paco2, medicaid, older obese participants, february, w, decoy, implantable cardioverter-defibrillator, noncardiologist, magnetic resonance spectroscopy, polymerase, percutaneous coronary revascularization, dodson et al with interest, imaging, abdominal problems, myofibre, rotterdam, cardioverter-defibrillator device, preserved ejection fraction development, heart failure readmission quality improvement initiative, hf symptom, cornerstone of heart failure, um, limited amount, grain, effective in myocytes, diagnostic evaluations, interesting, evaluated protein levels, interleukin, epigenetic, disappointments, carotid bodies, eg, prevents cell senescence, inotropes, lower svr index, lvad therapy, blinded core laboratory, canine model, virtual cohorts, treatment with crt-d, nursing interventions, months post-procedure, isolated myoctyes, healthy controls, intrinsic, feedback, neurological, preserved lvef experience, end-tidal co2, contractile, aim, long-term mortality after hospitalization, point, mesenchymal transition, concentric, academic, english, 4-year follow-up period, pressure-overload-induced heart, records, peptides, evidence gaps, reports, savings, improved tac, patients without uptitration, technology, strain rate at systole, peritoneal dialysis, baseline examination, fulfilling world health organization criteria, hgb level, transthoracic echocardiography, tumors, developed esrd, lower tapse, risk stratification for death, histone deacetylases, broad panel, conducting long-term, an, cumulative administration of doxorubicin, walk test distance, cell transplantation, comparable in patients, intermediate metabolism, ser83 mutant riα proteins, eighty-one percent, whites, cardiac looping, beta1-adrenergic receptor, subsequent heart, truncated, unfavourable clinical outcome, changes in prognosis, exhaustion, participating clinics, lower exercise, cardiac hypertrophy secondary to pressure-overload, cardiovascular disease, strengths, increasing ejection fraction, maintenance of sinus, stable heart failure patients, urgent all-cause readmission, multisite, unfamiliar physicians, diagnostic roles of bnp, pioglitazone, patient-level regression, high-sensitivity assay, uninephrectomy, analysis of patient management, emotional, heart failure hospitalizations in patients, depression scale, abnormal chamber patterning, open chest model, angiography, past decades, cardiomyocyte, orientation, resonance postcontrast, ongoing, advanced human hf, deficits, vasopressin receptor, common underlying characteristics, maximal medical treatment, developing congestive heart failure, impairment, health, minimal physical exertion, germline, increase in vo2max, introduction, poor prognosis, functioning, date of hf hospitalization, agonist, clinic outpatients, cost analysis of rhythm-control, combinations, diastolic mitral valve tethering, population-specific health interventions, rehabilitation in patient, spironolactone, worsening gls, progress in anticoagulation, strip, adjusted median rate ratio, longitudinal outcome-monitoring phase, major insulin-signaling components, renal function end point, all-cause readmission, elevated levels of plasma, resynchronization-defibrillation for ambulatory heart, confirmation, cancer, assist device implantations, physiological, transplant pool, grain intake, appendicular, clcnka snp, ambient air pollution, original construct, wild, parasympathetic, oht, relieve congestive symptoms, medical support, indicators, activated caspase, childhood malignant disease, enhancement, right ventricular function, repolarization instability in patients, diagnosed heart failure, infarction-both, severe anemia, disappearance, people with heart failure, rigorous investigation, coordinate dna accessibility, long-term, links, crt group, lvef, stem, neprilysin inhibitors, monomeric, tools, delivery, hopeful, change in percent, monophosphate, fluid retention, interactions with exercise training, higher hemoglobin levels, acs procedures, multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy, edema, health abc short physical performance battery, rehabilitation care, second trial, class iii to class, current, septum, included blood urea nitrogen, additional progress, effect of chf, crucial, rare, strong acid, stroke, heart failure ≤90 days after cabg, temporal, myocardial oxygen consumption, cardioprotection via inhibition, arterial systolic pressure, usual care, suburban, implicate, designs, dose uptitration, mesenchymal, mitochondrial oxidative metabolism, resistin, diagnosed heart, cardiology-cardiovascular surgery consensus report, obese body mass index categories, improved survival, left ventricular diastolic, enrichment analysis, depressive symptoms, at nonidentification, elevated levels of plasma norepinephrine, production of ec, cardiac remodeling, texture, longitudinal systolic, days of follow-up, filling pressures, protein expression, adverse event, left ventricular function assessment, follow-up after discharge, heart transplantation, systolic dysfunction, twofold, physiologic, ncdr pinnacle, generation nt-probnp assay, congenital abnormalities, global, types of heart failure, ventricular hypertrophy in heart failure, cutoff value, safety of spironolactone, kccq summary scores, care packages, robot-assisted, increased mrna level, beck depression inventory, serum resistin, myofiber shortening, specific research questions, injections, partial attenuation, axis, cumulative hazard, us healthcare programmes, center, eds, pef, time-dependent, matched cohort study, cardiovascular risk factors, test in patients, epidemic of heart failure, atherosclerotic, impaired angiogenesis, slope, mitral stenosis, retrospective, arm cuff, clinics, total symptom domains, hospital for heart failure, peripheral, improved health-related quality-of-life, individual scales, higher serum, myoctyes, c, urine, exchanges, induced, examine practice-level variation, 1b, active, composite quality measures, background—heart failure, high internal consistency among patients, treatment of heart failure, kccq overall summary, heart disease in patients, improvement in outcome ratings, isolated cabg, felt implantable cardioverter-defibrillator deactivation, introduced drug, decreased risk, examination of pka subunits, gaps, grounded theory, severe lv fibrosis, comparisons, rates, surgical indication for ms, index ed visit, paucity, end-systole, bromodomain proteins, hypertension, thoratec, mmhg, regional circumferential strain, liver disease, two-vessel disease model, hhf with saxagliptin, collected clinical data, period of pulseless, stay increase rehospitalization, role of irs1, decongestion, procedural adverse events, medical treatment for hf, fifty-four, physician specialty, alphalisa, beat-to-beat qt, hfref versus hfpef, thromboembolism, older breast cancer patients, partial, modest, negative rates of changes, qt variability, quotient, pro-b-type natriuretic peptide, reporting, trastuzumab-related, right coronary artery, morbidity, conduction, varying regional strain contributions, oldest, devices in heart failure, reviews, induction, claims, 6-month survival, main outcome measure, burden, ambient, contraindications, lv end-diastolic volume, steady decline in egfr, weak grip strength, henry, favour, physiologic processes in chf inhibition, mouse heart failure, surgical, adverse events, coronary syndromes, diagnosis of chf, results—retrospective cohort, improved label-free shotgun proteomics approach, hf volume management, requires confirmation, telehealth system, multiple cardiac genes in hf, scans, southeastern minnesota residents with hf, non-cachectic chf, york heart association, higher fat mass, effective rate control, chemical, involving young adults, n, defibrillator-only therapy, l-type channel, based practice centres, free, srd, outcomes for adults, care surgery, health care system, subgroups of patients, usual, data in duplicate, strain, potential clinical application, decision-support, renin-angiotensin-aldosterone, aortic valve repairs, pathway, cardiology practices, septal, dpp-4 inhibitors, vo2max, underlying hypertension, specific pde2 inhibition, equipotent, systolic pressure, targeting abnormal exercise, population-specific, or, haemodynamic outcomes in patients, underperfusion, initiation of therapy, familiar, emphasis-hf study, benefits in hf, industrial, lv diastolic dysfunction, coronary artery ligation, treatment of hfpef, separate cohort, rs8187710, xanthine, breath-holding, long-term management, pathophysiologic, levitated left ventricular assist system, current predictors of mortality, renal dnx, japanese, uniform nomenclature, long-standing persistent af, assessment, minor, cost-effective, new onset heart failure, sex-adjusted risk, noninvasive assessments, pathophysiological, voltage-gated, channel mrna splice, ii to iv hf, complete, blunts, 4-year, prospective, insulin action through activation, open surgery, cardioverter-defibrillator deactivation discussions, spironolactone in non-aas, abnormal, production, mitral regurgitation, extreme deciles, hnorm groups, composite quality measure, rem2, greater incidence, rapid, risk of death, lower fat mass index, proof-of-principle, atpase activity, acute right ventricular pressure overload, myocardium in response, beta-blocker therapy in patients, measure of hf, nontraumatic, clinician belief, institutional, chronic obstructive, stable situation, maintaining sinus rhythm, quality improvement, diastolic end, embolism, dietary measures, cardiac tissue, residents, advanced stages of heart failure, limitations, treating heart failure, surgical patients, prone, rankin score, total expenditure on health, β-adrenergic receptor blockade, hgb, matrix, bets, device therapies, secretion, wedge, cognitive, impaired right ventricular pump function, coronary perfusion in b-treated, gender, improves endothelial function, pool, special treatment, aortic valve replacement, long-term effects, length relations, chf inhibition of avp, bb dose, impaired, muscle aerobic capacity, occlusion, multivariate logistic regression, case-control, max, cardioverter-defibrillator therapy, reducing all-cause mortality, infarction patients, restrictive, experimental procedures, well-treated, multivariable, patient presentation, placebo groups, period, persistent af patients, detrimental alterations in skm, risk of incident cvd, hospitalization for hyperkalemia, oxidative stress, mild patients hospitalization, improve patient safety, paced myocardium, higher stroke volume, upcoming years, low-volume ed cases, microstructure, length of stay, wall cs, channel, exercise test, real-time, routine clinical tool for risk stratification, pasp increase, ischemic-hypertensive, unaffected, stable, beta, annular ms, pump replacement, years after hospitalization, beta-blocker, three-year, multiple, include recommendations, fat free mass, adipose tissue, high sensitivity, advanced disease, pre-participation, in-trial resource utilization, mediator of insulin resistance, timing, stable heart, brain natriuretic peptide, power, actrn12610001087044, biomarker-guided clinical trials, skilled, decrease in eo-cfus, left ventricular base, utilizing voluntary testimonies, hek, herbal medicine, family member st2, exchange, mapping, treating advanced hf, developing hyperkalemia, molecules, resistive, coronary disease, secondary outcome measures, cox proportional hazard models, trigger for excitation-contraction, non-diastolic, fragment, oxygen, fluid, project, common degs, p38alpha, oscillatory, biosynthetic, observational studies of transfusion, quality measures, achievement, nesiritide, maximal treadmill exercise testing, diastolic mitral flow, ninth revision, postcontrast t1 time, abundance during disease, obese older patients with hfpef, completion of training protocol, trigger, refractory cardiogenic, investigation, low-frequency, dilatation, natriuretic peptide levels, disclosing prognosis, intermuscular, common conditions, at-80, ie in patients, attention, post-translational modification of pka subunits, lower eo-cfus, cc, odds of chf, segment, ejection fractions, rac1, diagnoses, ventricular ejection, eo-cfus, activated neurohormonal systems, centrimag, pharmacological treatment, low testosterone, lipolysis, sodium-restricted dash diet, advanced, older adults with hf, vasopressin, functional classification, prospective assessment of body composition, consenting, acf, impaired cardiac, aerobic exercise per week, highest cumulative hazard, mixed linear models, benefit of crt-d, joint associations among cardiorespiratory fitness, et, failure samples, epinephrine, growth factor, underwent baseline echocardiography, healthy control, heart association class, breathing, single-payer perspective, marker, hospital admission, symptomatic chronic advanced heart failure patients, autonomic dysbalance, depolarization, diminished cyclic adenosine, scn5a, participant, adult mouse ventricular myocytes, post-hct, outcome assessment, hemodynamically stable, selecting patients, multiorgan, ss20, characteristics, enhancing neoangiogenesis, time-dependent cox regression analysis, signaling pathway, uptake of clinical practice guideline, chronic obstructive pulmonary, dt as implantation strategies, hf tissue, training for heart, detrimental alterations, loop, successful approaches, chf treatments, behavioural-change interventions, cytoskeletal actin, computational, inhospital outcomes, problematic, total ed visits, subcellular, international classification of diseases, simple clinical prediction rule, patients with thalassaemia major, worsened echocardiographic outcomes, southeastern, normal albumin concentration, left ventricular filling pressure response, faster, problem, chronic kidney disease epidemiology collaboration equation, lv size, hf concurrent with ami admission, mortality in heart failure, angiotensin receptor blockers in case, information, evidence in hfpef, follow-up levels of paf, isolated working hearts, vehicle-treated rats, qrs complex, heart failure model, contributions of titin, o2, late-onset hf, products, stage heart failure, postnatal mammalian myocardium with impact, tomographic, double, placebo group, antitumor activity, biomedical reasons, diminished, cardiac autonomic, category, rv dysfunction, hemolysis, atrial, furosemide dose, institutions, pharmacologic therapies, potential for success, consistent, effectiveness, sixty-one patients with hfpef, sitagliptin versus pioglitazone, pde2 expression, possibility of ms, 12-week, risk of ie, closure, avoidance, criteria cardiac transplant, c-statistics, pump, inappropriate therapy, currents, hemodynamically distinct, molecular level, cardiac troponin, lower hf mortality, synthesis, normal cardiac function, bradyarrhythmias, left ventricular dysfunction, pre-crt, adjustment for differences, mortality rate, rate control, outline, defibrillator implantation with cardiac, tapse-to-pasp ratio, catheter-based revascularization, energy x-ray absorptiometry, pathological changes, fifty-one, anterior descending, tolerance in heart failure, heart transplantations, beats, assist system, health-care budget, skilled nursing facilities, pleasanton, hospitalisation for heart failure, increased vagal, influence, water, left bundle branch, pb in patients, pediatric mechanical cardiac support, echocardiographic evidence, optimization, effect of ie, diet score, toxicity, evidence based practice, left ventricular biopsies, capability, ≥70 bpm, insulin receptor, white, bet, increased risk, common condition, pulmonary arterial systolic pressure relationship in heart failure, psoriasis, lower von willebrand factor concentrations, β-blocker, w rehabilitation, full advantage, chronic advanced heart failure patients, cardiac pathogenesis, non-ischemic, safety monitoring board, evaluated cpcs, risk of hf mortality, fraction, diastolic properties, interaction term, composite of repeat procedures, anaesthesia, rate ratio, attain maximal spironolactone dose, medicare data, receiving methotrexate, acute hf trials, self-care maintenance, atypical case, race influences efficacy, cardiogenic shock, office, new york heart association class ii, obese older patients with heart failure, patent, study design, xo inhibition, coefficients, nhs, dash diet scores, as, cardiac rehabilitation, irs2 double-knockout, health service, expression of type, substantial, receiving metoprolol, chronic inflammatory state, screened participants, novel percutaneous, statistics, initiation, blood loss, composite response, human embryonic kidney, hoc, processes of care delivery, 1-year mortality in 90-day survivors, relationship between length, improved functional, endoplasmic, intermediate care, nonpace, structurally normal, pd initiation, h-dko, prognostic value in patients, slow progression, cogeneration, qrs duration, severe heart failure, renal function, increased levels, analysis of patient management interventions, statistical, absence of jq1, slower increase in heart rate, new-onset, factor analysis, health abc hf, self-care of heart failure, functional mitral stenosis, complications, varying atrioventricular delay, multivariable cox modeling, young woman, pure hno donor, wt riα, association with exercise training response, health-related quality of life, raft, levels in patients, early physician, baseline characteristics, examining long-term outcomes, hemodynamic status, description, phosphomimic ser77, heart failure medicines, nonfailing, role of vasopressin, short-term improvements in functioning, simultaneous activation, favorable outcome, shocks, smad, advanced structural heart disease, overwhelming contribution, days of inclusion, trastuzumab-related cardiotoxicity, dacron, produced conflicting results, stroke volume, blood work, increased lung weight, pediatric, curative, novel therapeutic targets for heart failure, day, post-lvad ai, average age, signalling, determinant, rs1799945, perceptions, combined relative risk, aggravate cardiovascular health, acute treatment of heart failure, beta blockade, elevations in tumor necrosis factor, univariable analysis, threefold, routine bnp measurements, activators, multiple non-diastolic abnormalities, account, nursing care to outcomes, ec, anterior leaflet opening, administration of contrast agent, high-volume eds, mouse hf model, cholesterol, molecular analysis, energy x-ray, clinical characteristics results, heterochromatic, self-identified black patients, rv failure, congestion, cardioprotective, underwent mitral valve, sequence-specific binding, antirheumatic, pvf, systole, stable severe systolic heart failure, pathway alterations in tac, total cost per patient, failure in patients, kinase-2, association between psoriasis, year after discharge, algorithms, risk of hospital admission, nutritional strategies, black race in patients, endothelial, annular, associations of mediterranean, postcontrast t1, acute care hospitals, psss, cystatin c, fewer chf patients, paths, cpet, combined end point of death, relative appendicular lean mass index, 1515g→a, cardiac comorbidities, hf clinic, psoriasis patients, randomized aldactone, lower volumes of exercise, months of follow-up, transoesophageal echocardiographic guidance, autonomic balance, exhibits basal, vasodilator, rhythm, pool results, uv, low-dose, oxidase, frequent comorbidities in heart failure, papillary muscles, histological analysis, blood-flow, spontaneous, receptor blocker use, anterior descending artery, tracking va patients, aucs, calculated hfpsi, smaller, anemic, filling flow, distressing implantable cardioverter-defibrillator shocks, membrane oxygenation, active treatment, research requirements, significance, hypothesis-generating, hypertrophic, cardioverter, transplantations, ventilation, addition of gls, seventy-seven, expectancy, race, idiopathic, underwent lvad implantation, myocardial ischemic events in patients, edwards, blood flow, wall, improved clinical status, ruptures, care management, fewer cardioversions, greater, heart failure via activation, relative, costs for patients, differential response, regeneration, resistance training, interviews, ventricular filling pressure in patients, set, heavy, emergency cardiac catheterization, programs, α, net reclassification improvement, change in c-index, decoy vegf receptor, paradigm, blunted cardiac β-ar responsiveness, change in cystatin c, ed use, signs in hfpef, acute ischemic right heart failure, composite, ability of cardiomyocytes, low-sodium, cardiovascular conditions, hypertrophy, ventricular-arterial, limited mortality at hospital discharge, dose-dependent, kidney, assess risk, patients with chf-nyha-ii, emotional status, aac, salt intake, urinary tract infection, report severe perturbations, exclusion criteria, angiotensin-receptor, pharmacologic management, partial reduction, dimension, neurohormonal abnormalities, affairs, hemodynamics, glucocorticoid, operating characteristic curve, postoperative survival, thickness, β2-receptor haplotype status, co-ordinated fashion, tonometric, ami, prognosis in patients, dapc, patterns, nitrite, background—heart, risk stratification models, bioinformatic analysis of microarray data, ras blockers, reduce all-cause mortality, identified biomedical reasons, q66p, loading, cochrane library, underwent follow-up echocardiograms, nbdmard, recapitulates, auc, sympathetic nervous systems, unit, events, strata, left ventricular filling pressure, terminal regions, extended criteria, dual-energy x-ray absorptiometry, terminal, awareness, predictors, humoral stimuli, signalling cascades, culprit, if-channel, target dose, texas, outcome data, monoclonal, group of patients, right ventricular contractile function, infarcted rats, requiring revision, chronic heart failure in hungary, issues, corporeal membrane, concentration, bmi-matched, cutoff, observational studies, chronic heart failure, change, undergoing mt, risk-standardized mortality, b-treated, small muscle strips, lower rates of death, dyssynchrony, post-transplant morbidity, force, unfamiliar, considerable number of patients, nonfunctional channels, multivariate model, ventricular ejection time, improve mortality rates, ees, intestinal dysfunction, number of hf, exponent, patient with heart failure, unaltered, insurance status, kansas city cardiomyopathy questionnaire in patients, data extraction, belief, quintile of performance, underuse of eplerenone, pulmonary arterial pressure, risk of heart disease, patients with baseline ef, all-cause hospitalization, achieved study drug dose, atherosclerotic cad, optimizing cardiac progenitor function, augmented feedback, campbell, australian, 6-month observation period, palliation, skeletal muscle, 10-week, training for heart failure, iv, member, nontreatment, anaerobic metabolism, percent lean body mass, global longitudinal strain, values, β-adrenergic receptor blocker therapy, indeterminable, early-activated, c statistic, urban, projections, nris, acute autonomic nervous system modulation on qtv, classified patients, kcal, acute heart, higher oxygen flow, left ventricular tissue from control animals, dearth, trainings per week, patient management, metabolic risk, severe lv, human monocytes, randomized trial, stages, evidence, right ventricular contractile, aldosterone receptor antagonists, cr, extract data, baseline hrqol, non-biological, paf biosynthetic enzymes, addition of salt loading, essential for prevention, fractional shortening, differences in plasma b-type, moderate-severe, experienced pronounced decreases, np levels, included reoperation, acute anthracycline-induced cardiotoxicity, cm2, pre-post, adult, stop hypertension, cardiac index ≤, neurohormonal stimulation, physician adherence, elevated sympathetic activity, ang ii infusion, transforming growth factor, kidney infection, ventricular filling, ≥70 years, prolongation, matched-pairs, cardiomyopathy, nondiabetic, increased lv, venous thromboembolism, structured telephone support, exogenous variants, literature search, electromechanical behavior, cost-minimization approach, ischemic heart, heart rate reduction, multivariable regression, standardized nursing terminologies, independent prognostic markers, tachyarrhythmias, promising alternative, left ventricular diastolic end diameter, severity, nitric, 1-year, urgent cardiac transplant, diastolic filling, computed tomographic angiography, clinical comparisons, high sst2, unique indication, exercise rehabilitation in china, modulation, rate variability, lean zsf1 group, cox models, vad group, elements, united, transoesophageal echocardiography, proximal lad, involves cardiac hypertrophy, fetal, high-volume ed, medium, findings through briefing reports, treatment group effects on hrqol, reduced lv ejection fraction, higher exercise time, mild hf, predicting crt response, deletion, viable, inoperable chronic thromboembolic, diuretic, lv posterior wall thickness, 41-year-old man, furosemide, pacemakers, doppler echocardiography, crf, unreliable, cardiomyiopathy, regulating cellular metabolism, sdqt in hnorm subjects, typical, um cohort, studies with arni inhibitors, use of exercise, synthase, symptoms of hfpef, clustering, modest clinical benefit for patients, health abc hf risk model, concentric remodeling, ventricular longitudinal systolic strain, dash diet, high-fat, infancy, symptoms in patients, remodeling in systolic, quintiles, inconsistent results, bradycardic response, disease management programs in heart failure, scaling, ankle-brachial index, changes in pressure development, collins et al, worsening of heart failure, hospitalized heart failure among new users, measurements, mesenchymal transition markers, va-rt cohort, 6-month event rates, stimulation with sphingosine-1-phosphate, current study, olmsted county, shortening, heterogeneous group of patients, early research, cardioverter-defibrillator, magnetically levitated, hypertension with vasodilators, automatic defibrillator implantation with cardiac, pro75-arg76, incentives, implantable, mass index, cyclic, credible interval, heart magnetic resonance imaging on chelation choices, automatic defibrillator implantation, percutaneous coronary, june, incident, outcome of death, follow-up times, poor social support, interventions, malfunctions, human induced pluripotent stem, thromboembolic pulmonary hypertension, american college, medical treatment, poor, p-value, impaired cardiac metabolic, operation, rnas, congestive heart failure phenotypes, failure with preserved, world health organization website, decreases in septum, reduced irs1, mrna level, cost, rna, left ventricular midpapillary level, standard, proportional to lv, complications of therapy, received spironolactone, therapeutic strategies, patients with qrs prolongation, influence medical resource use, slow hf evolution, accumulating evidence, target sodium, northern, rat, partially reversible, coronary interventions, 6-week, specificity, free wall rs, abc, managed diseases, cardioverter defibrillator-crt, nursing outcomes classification, biomarker-guided clinical trial, multivariate assessment, parallel, sphingosine-1-phosphate, enzyme inhibitors, basal contractility, ratio of lv strain rate, exertional increase, systolic elastance, af-free, fatty, lower 6-minute walking distance, dhand, modest effects on heart failure, pharmacologic treatment, mm, step, users of saxagliptin, interaction between race, safety, polymorphisms, 6-month risk, way, paf levels, chronic decompensated heart failure, undergone, multivariable-adjusted hazard ratios, industrial areas, raised blood glucose levels, lv strain, interventions in heart failure cost-effectiveness, dyssynchronous heart, functional class ii, gross morphological development, neutral endopeptidase inhibitors, work, hf mortality, clinical care delivery, class iii hf, β-myosin heavy chain